BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 373522 COc1nccc2oc(cc12)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H19N5O4/c1-25-19-13-8-16(28-15(13)4-5-21-19)14-10-22-17-2-3-18(23-24(14)17)27-11-12-9-20-6-7-26-12/h2-5,8,10,12,20H,6-7,9,11H2,1H3/t12-/m1/s1 OJBINZYFXHKYFD-GFCCVEGCSA-N 211961 US9290482, 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211961&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71745108 329587838 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373523 COc1nccc2oc(cc12)-c1cnc2ccc(OCC3CNC3)nn12 InChI=1S/C18H17N5O3/c1-24-18-12-6-15(26-14(12)4-5-20-18)13-9-21-16-2-3-17(22-23(13)16)25-10-11-7-19-8-11/h2-6,9,11,19H,7-8,10H2,1H3 OEQQISQELMRZDV-UHFFFAOYSA-N 211962 US9290482, 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 31 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211962&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71767455 329587839 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373524 CN[C@H](C)COc1ccc2ncc(-c3cc4c(OC)nccc4o3)n2n1 InChI=1S/C18H19N5O3/c1-11(19-2)10-25-17-5-4-16-21-9-13(23(16)22-17)15-8-12-14(26-15)6-7-20-18(12)24-3/h4-9,11,19H,10H2,1-3H3/t11-/m1/s1 RZLRCYVNAIVXJZ-LLVKDONJSA-N 211963 US9290482, 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 32 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211963&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 117983450 329587840 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373525 C(Oc1ccc2ncc(-c3cc4cnccc4o3)n2n1)[C@H]1CNCCO1 InChI=1S/C18H17N5O3/c1-2-18(25-11-13-9-20-5-6-24-13)22-23-14(10-21-17(1)23)16-7-12-8-19-4-3-15(12)26-16/h1-4,7-8,10,13,20H,5-6,9,11H2/t13-/m1/s1 IPNYCEXMDHIURA-CYBMUJFWSA-N 211964 US9290482, 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 72 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211964&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71767457 329587841 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373526 C(Oc1ccc2ncc(-c3cc4ncccc4o3)n2n1)[C@H]1CNCCO1 InChI=1S/C18H17N5O3/c1-2-15-13(20-5-1)8-16(26-15)14-10-21-17-3-4-18(22-23(14)17)25-11-12-9-19-6-7-24-12/h1-5,8,10,12,19H,6-7,9,11H2/t12-/m1/s1 IDWSMFWRDJCZMC-GFCCVEGCSA-N 211965 US9290482, 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 86 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211965&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71767458 329587842 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373527 C(C[C@@H]1CCCN1)Oc1ccc2ncc(-c3cc4cnccc4o3)n2n1 InChI=1S/C19H19N5O2/c1-2-14(21-7-1)6-9-25-19-4-3-18-22-12-15(24(18)23-19)17-10-13-11-20-8-5-16(13)26-17/h3-5,8,10-12,14,21H,1-2,6-7,9H2/t14-/m0/s1 QKFNKHFBSWHFSI-AWEZNQCLSA-N 211966 US9290482, 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 132 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211966&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71767597 329587843 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373528 COc1nccc2oc(cc12)-c1cnc2ccc(O[C@@H](CNC3CC3)c3ccc(F)cc3)nn12 InChI=1S/C25H22FN5O3/c1-32-25-18-12-21(33-20(18)10-11-27-25)19-13-29-23-8-9-24(30-31(19)23)34-22(14-28-17-6-7-17)15-2-4-16(26)5-3-15/h2-5,8-13,17,22,28H,6-7,14H2,1H3/t22-/m0/s1 VSJAKGNURUOQAM-QFIPXVFZSA-N 211967 US9290482, 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 389 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211967&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 117983451 329587844 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 373529 COc1nccc2oc(cc12)-c1cnc2ccc(OCC3CCCCN3)nn12 InChI=1S/C20H21N5O3/c1-26-20-14-10-17(28-16(14)7-9-22-20)15-11-23-18-5-6-19(24-25(15)18)27-12-13-4-2-3-8-21-13/h5-7,9-11,13,21H,2-4,8,12H2,1H3 WFGGSCDJNHNYQI-UHFFFAOYSA-N 211968 US9290482, 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 48 7.5 22.00 C US Patent 10.7270/Q2B856ZD aid1802367 US9290482 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211968&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 123365923 329587845 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389824 COc1cccc2oc(cc12)-c1cnc2ccc(OCCCSC)nn12 InChI=1S/C19H19N3O3S/c1-23-15-5-3-6-16-13(15)11-17(25-16)14-12-20-18-7-8-19(21-22(14)18)24-9-4-10-26-2/h3,5-8,11-12H,4,9-10H2,1-2H3 BRMQJERPCBXXKN-UHFFFAOYSA-N 223020 US9320737, I.1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223020&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 89463794 335961852 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389825 CSCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N3O2S/c1-24-10-4-9-22-18-8-7-17-19-12-14(21(17)20-18)16-11-13-5-2-3-6-15(13)23-16/h2-3,5-8,11-12H,4,9-10H2,1H3 NILXTZBRELPADO-UHFFFAOYSA-N 223021 US9320737, I.2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223021&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538106 335961853 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389826 CSCCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N3O2S/c1-25-11-5-4-10-23-19-9-8-18-20-13-15(22(18)21-19)17-12-14-6-2-3-7-16(14)24-17/h2-3,6-9,12-13H,4-5,10-11H2,1H3 IEOACKAOCBHSME-UHFFFAOYSA-N 223022 US9320737, I.3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 27 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223022&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538109 335961854 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389827 CSCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H15N3O2S/c1-23-9-8-21-17-7-6-16-18-11-13(20(16)19-17)15-10-12-4-2-3-5-14(12)22-15/h2-7,10-11H,8-9H2,1H3 BLJWJCAQPDTGCS-UHFFFAOYSA-N 223023 US9320737, I.4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 16 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223023&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538108 335961855 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389828 COc1cccc2oc(cc12)-c1cnc2ccc(OCCCS(C)=O)nn12 InChI=1S/C19H19N3O4S/c1-24-15-5-3-6-16-13(15)11-17(26-16)14-12-20-18-7-8-19(21-22(14)18)25-9-4-10-27(2)23/h3,5-8,11-12H,4,9-10H2,1-2H3 DTLCVMCGNBLCPO-UHFFFAOYSA-N 223024 US9320737, II.1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223024&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71506852 335961856 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389829 CS(=O)CCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N3O3S/c1-25(22)10-4-9-23-18-8-7-17-19-12-14(21(17)20-18)16-11-13-5-2-3-6-15(13)24-16/h2-3,5-8,11-12H,4,9-10H2,1H3 OARQRIONHZACAE-UHFFFAOYSA-N 223025 US9320737, II.2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223025&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538110 335961857 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389830 CS(=O)CCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N3O3S/c1-26(23)11-5-4-10-24-19-9-8-18-20-13-15(22(18)21-19)17-12-14-6-2-3-7-16(14)25-17/h2-3,6-9,12-13H,4-5,10-11H2,1H3 UOSFMIJOOFCUID-UHFFFAOYSA-N 223026 US9320737, II.3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223026&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538382 335961858 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389831 CS(=O)CCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H15N3O3S/c1-24(21)9-8-22-17-7-6-16-18-11-13(20(16)19-17)15-10-12-4-2-3-5-14(12)23-15/h2-7,10-11H,8-9H2,1H3 IDDDYGQGNOINMS-UHFFFAOYSA-N 223027 US9320737, II.4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223027&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538381 335961859 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389832 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N3O4S/c1-26(22,23)10-4-9-24-18-8-7-17-19-12-14(21(17)20-18)16-11-13-5-2-3-6-15(13)25-16/h2-3,5-8,11-12H,4,9-10H2,1H3 TXPLNEQLEQXZOV-UHFFFAOYSA-N 223028 US9320737, III.1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223028&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538383 335961860 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389833 COc1ccc2oc(cc2c1)-c1cnc2ccc(OCCCS(C)(=O)=O)nn12 InChI=1S/C19H19N3O5S/c1-25-14-4-5-16-13(10-14)11-17(27-16)15-12-20-18-6-7-19(21-22(15)18)26-8-3-9-28(2,23)24/h4-7,10-12H,3,8-9H2,1-2H3 BCTFMWHRJALYEU-UHFFFAOYSA-N 223029 US9320737, III.2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223029&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538387 335961861 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389834 COc1cccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=O)=O)nn12 InChI=1S/C19H19N3O5S/c1-25-15-5-3-6-16-13(15)11-17(27-16)14-12-20-18-7-8-19(21-22(14)18)26-9-4-10-28(2,23)24/h3,5-8,11-12H,4,9-10H2,1-2H3 UMNYFJQMXNJPBH-UHFFFAOYSA-N 223030 US9320737, III.3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223030&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538385 335961862 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389835 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4cc(F)ccc4o3)n2n1 InChI=1S/C18H16FN3O4S/c1-27(23,24)8-2-7-25-18-6-5-17-20-11-14(22(17)21-18)16-10-12-9-13(19)3-4-15(12)26-16/h3-6,9-11H,2,7-8H2,1H3 LTWXWWRYQNDMAK-UHFFFAOYSA-N 223031 US9320737, III.4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223031&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538384 335961863 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389836 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4cc(Cl)ccc4o3)n2n1 InChI=1S/C18H16ClN3O4S/c1-27(23,24)8-2-7-25-18-6-5-17-20-11-14(22(17)21-18)16-10-12-9-13(19)3-4-15(12)26-16/h3-6,9-11H,2,7-8H2,1H3 NHAMQGDRIHWWCM-UHFFFAOYSA-N 223032 US9320737, III.5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223032&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538386 335961864 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389837 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4cccc(F)c4o3)n2n1 InChI=1S/C18H16FN3O4S/c1-27(23,24)9-3-8-25-17-7-6-16-20-11-14(22(16)21-17)15-10-12-4-2-5-13(19)18(12)26-15/h2,4-7,10-11H,3,8-9H2,1H3 QDKVKRYEGGLKQC-UHFFFAOYSA-N 223033 US9320737, III.6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 48 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223033&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538655 335961865 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389838 Cc1c(oc2ccccc12)-c1cnc2ccc(OCCCS(C)(=O)=O)nn12 InChI=1S/C19H19N3O4S/c1-13-14-6-3-4-7-16(14)26-19(13)15-12-20-17-8-9-18(21-22(15)17)25-10-5-11-27(2,23)24/h3-4,6-9,12H,5,10-11H2,1-2H3 NCHLFUDIWZQSHN-UHFFFAOYSA-N 223034 US9320737, III.7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 61 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223034&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538656 335961866 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389839 Cc1cccc2cc(oc12)-c1cnc2ccc(OCCCS(C)(=O)=O)nn12 InChI=1S/C19H19N3O4S/c1-13-5-3-6-14-11-16(26-19(13)14)15-12-20-17-7-8-18(21-22(15)17)25-9-4-10-27(2,23)24/h3,5-8,11-12H,4,9-10H2,1-2H3 XFVVHIYODBWRAT-UHFFFAOYSA-N 223035 US9320737, III.8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 70 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223035&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538657 335961867 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389840 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4c(F)cccc4o3)n2n1 InChI=1S/C18H16FN3O4S/c1-27(23,24)9-3-8-25-18-7-6-17-20-11-14(22(17)21-18)16-10-12-13(19)4-2-5-15(12)26-16/h2,4-7,10-11H,3,8-9H2,1H3 RAPOHHXIZMPZAI-UHFFFAOYSA-N 223036 US9320737, III.9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223036&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538659 335961868 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389841 Cc1cc2ncc(-c3cc4ccccc4o3)n2nc1OCCCS(C)(=O)=O InChI=1S/C19H19N3O4S/c1-13-10-18-20-12-15(17-11-14-6-3-4-7-16(14)26-17)22(18)21-19(13)25-8-5-9-27(2,23)24/h3-4,6-7,10-12H,5,8-9H2,1-2H3 NSJQVARBDFJVFQ-UHFFFAOYSA-N 223037 US9320737, III.10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223037&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538660 335961869 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389842 CS(=O)(=O)CCCOc1nn2c(cnc2cc1-c1ccccc1)-c1cc2ccccc2o1 InChI=1S/C24H21N3O4S/c1-32(28,29)13-7-12-30-24-19(17-8-3-2-4-9-17)15-23-25-16-20(27(23)26-24)22-14-18-10-5-6-11-21(18)31-22/h2-6,8-11,14-16H,7,12-13H2,1H3 VGPYTVROUCWIRH-UHFFFAOYSA-N 223038 US9320737, III.11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223038&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538658 335961870 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389843 COc1nccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=O)=O)nn12 InChI=1S/C18H18N4O5S/c1-25-18-12-10-15(27-14(12)6-7-19-18)13-11-20-16-4-5-17(21-22(13)16)26-8-3-9-28(2,23)24/h4-7,10-11H,3,8-9H2,1-2H3 RBFQIOHPMCPMFR-UHFFFAOYSA-N 223039 US9320737, III.12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223039&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71534710 335961871 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389844 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4cnccc4o3)n2n1 InChI=1S/C17H16N4O4S/c1-26(22,23)8-2-7-24-17-4-3-16-19-11-13(21(16)20-17)15-9-12-10-18-6-5-14(12)25-15/h3-6,9-11H,2,7-8H2,1H3 NIFVMRGIOHOGKD-UHFFFAOYSA-N 223040 US9320737, III.13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 28 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223040&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538951 335961872 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389845 CS(=O)(=O)CCCOc1ccc2ncc(-c3cc4ncccc4o3)n2n1 InChI=1S/C17H16N4O4S/c1-26(22,23)9-3-8-24-17-6-5-16-19-11-13(21(16)20-17)15-10-12-14(25-15)4-2-7-18-12/h2,4-7,10-11H,3,8-9H2,1H3 ZFAPZAUNIBKWFG-UHFFFAOYSA-N 223041 US9320737, III.14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 60 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223041&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71538950 335961873 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389846 COc1cccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=O)=NC(=O)C(F)(F)F)nn12 InChI=1S/C21H19F3N4O5S/c1-31-15-5-3-6-16-13(15)11-17(33-16)14-12-25-18-7-8-19(26-28(14)18)32-9-4-10-34(2,30)27-20(29)21(22,23)24/h3,5-8,11-12H,4,9-10H2,1-2H3 COFXUPHNZJKPOK-UHFFFAOYSA-N 223042 US9320737, IV.1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223042&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71534712 335961874 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389847 COc1cccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=N)=O)nn12 InChI=1S/C19H20N4O4S/c1-25-15-5-3-6-16-13(15)11-17(27-16)14-12-21-18-7-8-19(22-23(14)18)26-9-4-10-28(2,20)24/h3,5-8,11-12,20H,4,9-10H2,1-2H3 DLZQHAOUJWYOTJ-UHFFFAOYSA-N 223043 US9320737, IV.2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223043&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78103723 335961875 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389848 CS(=O)(CCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1)=NC(=O)C(F)(F)F InChI=1S/C20H17F3N4O4S/c1-32(29,26-19(28)20(21,22)23)10-4-9-30-18-8-7-17-24-12-14(27(17)25-18)16-11-13-5-2-3-6-15(13)31-16/h2-3,5-8,11-12H,4,9-10H2,1H3 LAXOPSMOSMZQRO-UHFFFAOYSA-N 223044 US9320737, IV.3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223044&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71534711 335961876 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389849 CS(=N)(=O)CCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H18N4O3S/c1-26(19,23)10-4-9-24-18-8-7-17-20-12-14(22(17)21-18)16-11-13-5-2-3-6-15(13)25-16/h2-3,5-8,11-12,19H,4,9-10H2,1H3 NUOHTNYHORIQRD-UHFFFAOYSA-N 223045 US9320737, IV.4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223045&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78103722 335961877 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389850 CS(=O)(CCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1)=NC(=O)C(F)(F)F InChI=1S/C21H19F3N4O4S/c1-33(30,27-20(29)21(22,23)24)11-5-4-10-31-19-9-8-18-25-13-15(28(18)26-19)17-12-14-6-2-3-7-16(14)32-17/h2-3,6-9,12-13H,4-5,10-11H2,1H3 PTLVFZKBZYNACH-UHFFFAOYSA-N 223047 US9320737, IV.5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223047&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71534713 335961878 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389851 CS(=N)(=O)CCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H20N4O3S/c1-27(20,24)11-5-4-10-25-19-9-8-18-21-13-15(23(18)22-19)17-12-14-6-2-3-7-16(14)26-17/h2-3,6-9,12-13,20H,4-5,10-11H2,1H3 LGWXMHXYMHMZNY-UHFFFAOYSA-N 223048 US9320737, IV.6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223048&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78103720 335961879 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389852 CS(=O)(CCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1)=NC(=O)C(F)(F)F InChI=1S/C19H15F3N4O4S/c1-31(28,25-18(27)19(20,21)22)9-8-29-17-7-6-16-23-11-13(26(16)24-17)15-10-12-4-2-3-5-14(12)30-15/h2-7,10-11H,8-9H2,1H3 QPBHKIUVEBNLQM-UHFFFAOYSA-N 223049 US9320737, IV.7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 47 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223049&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71534714 335961880 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389853 CS(=O)(CCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1)=NC#N InChI=1S/C19H17N5O3S/c1-28(25,22-13-20)10-4-9-26-19-8-7-18-21-12-15(24(18)23-19)17-11-14-5-2-3-6-16(14)27-17/h2-3,5-8,11-12H,4,9-10H2,1H3 IHUSDVVWAWWCBX-UHFFFAOYSA-N 223050 US9320737, IV.8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223050&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71535015 335961881 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389854 COc1nccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=O)=NC#N)nn12 InChI=1S/C19H18N6O4S/c1-27-19-13-10-16(29-15(13)6-7-21-19)14-11-22-17-4-5-18(24-25(14)17)28-8-3-9-30(2,26)23-12-20/h4-7,10-11H,3,8-9H2,1-2H3 QPQGESIICFUNKN-UHFFFAOYSA-N 223051 US9320737, IV.9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223051&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 90336355 335961882 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 389855 COc1nccc2oc(cc12)-c1cnc2ccc(OCCCS(C)(=N)=O)nn12 InChI=1S/C18H19N5O4S/c1-25-18-12-10-15(27-14(12)6-7-20-18)13-11-21-16-4-5-17(22-23(13)16)26-8-3-9-28(2,19)24/h4-7,10-11,19H,3,8-9H2,1-2H3 OWGOKZPGUVVMKC-UHFFFAOYSA-N 223052 US9320737, IV.10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9 7.5 22.00 C US Patent 10.7270/Q22V2F00 aid1802630 US9320737 Eis, K; Puehler, F; Zorn, L; Scholz, A; Lienau, P; Gnoth, MJ; Bomer, U; Gunther, J Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=223052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=223052&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78103721 335961883 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474609 O=c1[nH]c2ccc(Nc3ncnc4sc(CC5CC5)nc34)cc2s1 InChI=1S/C16H13N5OS2/c22-16-20-10-4-3-9(6-11(10)23-16)19-14-13-15(18-7-17-14)24-12(21-13)5-8-1-2-8/h3-4,6-8H,1-2,5H2,(H,20,22)(H,17,18,19) KVTOGWASAODVEB-UHFFFAOYSA-N 176745 US9675612, 1 6-{[2-(Cyclopropylmethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 37 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176745&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321818 363893390 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474610 O=c1[nH]c2ccc(Nc3ncnc4sc(nc34)C3CCC3)cc2s1 InChI=1S/C16H13N5OS2/c22-16-20-10-5-4-9(6-11(10)23-16)19-13-12-15(18-7-17-13)24-14(21-12)8-2-1-3-8/h4-8H,1-3H2,(H,20,22)(H,17,18,19) KLERMRAOMZWPMK-UHFFFAOYSA-N 176746 US9675612, 2 6-[(2-Cyclobutyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 87 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176746&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321819 363893391 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474611 O=c1[nH]c2ccc(Nc3ncnc4sc(nc34)C3CCCCC3)cc2s1 InChI=1S/C18H17N5OS2/c24-18-22-12-7-6-11(8-13(12)25-18)21-15-14-17(20-9-19-15)26-16(23-14)10-4-2-1-3-5-10/h6-10H,1-5H2,(H,22,24)(H,19,20,21) JOBHAMQGNCYJLI-UHFFFAOYSA-N 176747 US9675612, 3 6-[(2-Cyclohexyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 197 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176747&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321820 363893392 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474612 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(Cc3ccccc3)nc12 InChI=1S/C20H16N6OS/c1-27-16-9-14-13(10-23-26-14)8-15(16)24-19-18-20(22-11-21-19)28-17(25-18)7-12-5-3-2-4-6-12/h2-6,8-11H,7H2,1H3,(H,23,26)(H,21,22,24) YVRHMSDAWKCNBE-UHFFFAOYSA-N 176749 US9675612, 4 2-Benzyl-N-(6-methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 20 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176749&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321821 363893393 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474613 COCc1nc2c(Nc3cc4cn[nH]c4cc3OC)ncnc2s1 InChI=1S/C15H14N6O2S/c1-22-6-12-20-13-14(16-7-17-15(13)24-12)19-10-3-8-5-18-21-9(8)4-11(10)23-2/h3-5,7H,6H2,1-2H3,(H,18,21)(H,16,17,19) NABFBTGSEDBUJN-UHFFFAOYSA-N 176754 US9675612, 5 N-(6-Methoxy-1H-indazol-5-yl)-2-(methoxymethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176754&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322124 363893397 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474614 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(nc12)C1CCCCC1 InChI=1S/C19H19N5O2S2/c1-26-13-7-12-14(27-19(25)23-12)8-11(13)22-16-15-18(21-9-20-16)28-17(24-15)10-5-3-2-4-6-10/h7-10H,2-6H2,1H3,(H,23,25)(H,20,21,22) YEDGAQYUGFJXFR-UHFFFAOYSA-N 176757 US9675612, 7 6-[(2-Cyclohexyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-5-methoxy-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 354 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176757&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322126 363893399 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474615 C1CCC(CC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H18N6S/c1-2-4-11(5-3-1)17-23-15-16(19-10-20-18(15)25-17)22-13-6-7-14-12(8-13)9-21-24-14/h6-11H,1-5H2,(H,21,24)(H,19,20,22) ZCZORJWUOGQOPQ-UHFFFAOYSA-N 176761 US9675612, 8 2-Cyclohexyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 56 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176761&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322128 363893403 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474616 C(C1CC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C16H14N6S/c1-2-9(1)5-13-21-14-15(17-8-18-16(14)23-13)20-11-3-4-12-10(6-11)7-19-22-12/h3-4,6-9H,1-2,5H2,(H,19,22)(H,17,18,20) CNEUDEVUGXYSLX-UHFFFAOYSA-N 176763 US9675612, 9 2-(Cyclopropylmethyl)-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176763&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322127 363893405 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474617 C1CC(C1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C16H14N6S/c1-2-9(3-1)15-21-13-14(17-8-18-16(13)23-15)20-11-4-5-12-10(6-11)7-19-22-12/h4-9H,1-3H2,(H,19,22)(H,17,18,20) DYAXDJBXKYCKQQ-UHFFFAOYSA-N 176766 US9675612, 10 2-Cyclobutyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 54 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176766&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322129 363893407 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474618 C(c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1)c1ccccc1 InChI=1S/C19H14N6S/c1-2-4-12(5-3-1)8-16-24-17-18(20-11-21-19(17)26-16)23-14-6-7-15-13(9-14)10-22-25-15/h1-7,9-11H,8H2,(H,22,25)(H,20,21,23) YFLGGBCOCXFXSQ-UHFFFAOYSA-N 176767 US9675612, 11 2-Benzyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 35 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176767&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081876 363893408 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474619 CC1(O)CN(C1)C(=O)CCCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C20H21N7O2S/c1-20(29)9-27(10-20)16(28)4-2-3-15-25-17-18(21-11-22-19(17)30-15)24-13-5-6-14-12(7-13)8-23-26-14/h5-8,11,29H,2-4,9-10H2,1H3,(H,23,26)(H,21,22,24) KHEAIXVLABOYHQ-UHFFFAOYSA-N 176769 US9675612, 12 1-(3-Hydroxy-3-methylazetidin-1-yl)-4-[7-(1H-indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]butan-1-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 173 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176769&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322431 363893410 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474620 CN(C)C(=O)CCCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H19N7OS/c1-25(2)15(26)5-3-4-14-23-16-17(19-10-20-18(16)27-14)22-12-6-7-13-11(8-12)9-21-24-13/h6-10H,3-5H2,1-2H3,(H,21,24)(H,19,20,22) RQIPQFCWMZHYFW-UHFFFAOYSA-N 176770 US9675612, 13 4-[7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-N,N-dimethylbutanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 122 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176770&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324015 363893411 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474621 CC1(O)CN(C1)C(=O)CCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C19H19N7O2S/c1-19(28)8-26(9-19)15(27)5-4-14-24-16-17(20-10-21-18(16)29-14)23-12-2-3-13-11(6-12)7-22-25-13/h2-3,6-7,10,28H,4-5,8-9H2,1H3,(H,22,25)(H,20,21,23) ZOAUVUPYVLBWMI-UHFFFAOYSA-N 176771 US9675612, 14 1-(3-Hydroxy-3-methylazetidin-1-yl)-3-[7-(1H-indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]propan-1-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 126 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176771&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322429 363893412 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474622 COc1cc2[nH]ncc2cc1Nc1ncnc2scnc12 InChI=1S/C13H10N6OS/c1-20-10-3-8-7(4-17-19-8)2-9(10)18-12-11-13(15-5-14-12)21-6-16-11/h2-6H,1H3,(H,17,19)(H,14,15,18) SYJNMKWDALZJGZ-UHFFFAOYSA-N 176772 US9675612, 15 N-(6-Methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 47 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176772&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322430 363893413 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474623 N(c1ccc2[nH]ncc2c1)c1ncnc2scnc12 InChI=1S/C12H8N6S/c1-2-9-7(4-16-18-9)3-8(1)17-11-10-12(14-5-13-11)19-6-15-10/h1-6H,(H,16,18)(H,13,14,17) WEGGSUIYJJSKGU-UHFFFAOYSA-N 176773 US9675612, 16 N-(1H-Indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 186 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176773&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324014 363893414 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474624 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C23H22N6OS/c1-14(2)30-19-11-17-16(12-26-29-17)10-18(19)27-22-21-23(25-13-24-22)31-20(28-21)9-8-15-6-4-3-5-7-15/h3-7,10-14H,8-9H2,1-2H3,(H,26,29)(H,24,25,27) FTJIPXCJVBZCBX-UHFFFAOYSA-N 176774 US9675612, 17 2-(2-Phenylethyl)-N-[6-(propan-2-yloxy)-1H-indazol-5-yl][1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 229 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176774&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081877 363893415 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474625 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2scnc12 InChI=1S/C13H9N5O2S2/c1-20-8-2-7-9(22-13(19)18-7)3-6(8)17-11-10-12(15-4-14-11)21-5-16-10/h2-5H,1H3,(H,18,19)(H,14,15,17) HFHJQINGOOBDPG-UHFFFAOYSA-N 176775 US9675612, 18 5-Methoxy-6-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 104 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176775&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322432 363893416 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474626 O=c1[nH]c2ccc(Nc3ncnc4scnc34)cc2s1 InChI=1S/C12H7N5OS2/c18-12-17-7-2-1-6(3-8(7)20-12)16-10-9-11(14-4-13-10)19-5-15-9/h1-5H,(H,17,18)(H,13,14,16) UJZFMVNJBQCZEK-UHFFFAOYSA-N 176776 US9675612, 19 6-([1,3]Thiazolo[5,4-d]pyrimidin-7-ylamino)-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 159 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176776&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322435 363893417 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474627 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(COCc3ccccc3)nc12 InChI=1S/C21H18N6O2S/c1-28-17-8-15-14(9-24-27-15)7-16(17)25-20-19-21(23-12-22-20)30-18(26-19)11-29-10-13-5-3-2-4-6-13/h2-9,12H,10-11H2,1H3,(H,24,27)(H,22,23,25) BULRVIAVJLIGCX-UHFFFAOYSA-N 176777 US9675612, 20 2-[(Benzyloxy)methyl]-N-(6-methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176777&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322434 363893418 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474628 CN(C)C(=O)CCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C17H17N7OS/c1-24(2)14(25)6-5-13-22-15-16(18-9-19-17(15)26-13)21-11-3-4-12-10(7-11)8-20-23-12/h3-4,7-9H,5-6H2,1-2H3,(H,20,23)(H,18,19,21) KEYAXZNNOKHTNA-UHFFFAOYSA-N 176778 US9675612, 21 3-[7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-N,N-dimethylpropanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 100 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176778&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324013 363893419 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474629 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C21H18N6OS/c1-28-17-10-15-14(11-24-27-15)9-16(17)25-20-19-21(23-12-22-20)29-18(26-19)8-7-13-5-3-2-4-6-13/h2-6,9-12H,7-8H2,1H3,(H,24,27)(H,22,23,25) SAVRDDXYWDOTBR-UHFFFAOYSA-N 176779 US9675612, 22 N-(6-Methoxy-1H-indazol-5-yl)-2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 38 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176779&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081878 363893420 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474630 C(Cc1ccccc1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C20H16N6S/c1-2-4-13(5-3-1)6-9-17-25-18-19(21-12-22-20(18)27-17)24-15-7-8-16-14(10-15)11-23-26-16/h1-5,7-8,10-12H,6,9H2,(H,23,26)(H,21,22,24) PHURRAYIJKZDIK-UHFFFAOYSA-N 176780 US9675612, 23 N-(1H-indazol-5-yl)-2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 51 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176780&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081879 363893421 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474631 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C21H17N5O2S2/c1-28-15-9-14-16(29-21(27)25-14)10-13(15)24-19-18-20(23-11-22-19)30-17(26-18)8-7-12-5-3-2-4-6-12/h2-6,9-11H,7-8H2,1H3,(H,25,27)(H,22,23,24) PDQZQTBABJNURP-UHFFFAOYSA-N 176782 US9675612, 25 5-Methoxy-6-{[2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10000 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176782&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322753 363893422 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474632 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCCC(=O)N(C)C)nc12 InChI=1S/C19H21N7O2S/c1-26(2)16(27)6-4-5-15-24-17-18(20-10-21-19(17)29-15)23-13-7-11-9-22-25-12(11)8-14(13)28-3/h7-10H,4-6H2,1-3H3,(H,22,25)(H,20,21,23) LOQIDZDIKMNNIH-UHFFFAOYSA-N 176783 US9675612, 26 4-{7-[(6-Methoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}-N, N-dimethylbutanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 85 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176783&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322754 363893423 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474633 CN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C15H12N6O2S2/c1-21(2)14(22)13-20-10-11(16-6-17-12(10)25-13)18-7-3-4-8-9(5-7)24-15(23)19-8/h3-6H,1-2H3,(H,19,23)(H,16,17,18) JBLDGANSEOAEBH-UHFFFAOYSA-N 176784 US9675612, 27 N,N-Dimethyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 408 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176784&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322755 363893424 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474634 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C16H14N6O3S2/c1-22(2)15(23)14-21-11-12(17-6-18-13(11)27-14)19-7-5-10-8(4-9(7)25-3)20-16(24)26-10/h4-6H,1-3H3,(H,20,24)(H,17,18,19) WHXOJFLHDLEWEL-UHFFFAOYSA-N 176785 US9675612, 28 7-[(5-Methoxy-2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino]-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1080 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176785&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322756 363893425 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474635 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C16H15N7O2S/c1-23(2)16(24)15-21-12-13(17-7-18-14(12)26-15)20-10-4-8-6-19-22-9(8)5-11(10)25-3/h4-7H,1-3H3,(H,19,22)(H,17,18,20) OJTUGJMQDUSDMJ-UHFFFAOYSA-N 176790 US9675612, 29 7-[(6-Methoxy-1H-indazol-5-yl)amino]-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 199 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176790&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323062 363893426 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474636 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C17H17N7O2S/c1-4-26-12-6-10-9(7-20-23-10)5-11(12)21-14-13-15(19-8-18-14)27-16(22-13)17(25)24(2)3/h5-8H,4H2,1-3H3,(H,20,23)(H,18,19,21) WRSLSMOUHFZACQ-UHFFFAOYSA-N 176791 US9675612, 30 7-[(6-Ethoxy-1H-indazol-5-yl)amino]-N, N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 42 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176791&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323063 363893427 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474637 O=C(N1CCCCC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H17N7OS/c26-18(25-6-2-1-3-7-25)17-23-14-15(19-10-20-16(14)27-17)22-12-4-5-13-11(8-12)9-21-24-13/h4-5,8-10H,1-3,6-7H2,(H,21,24)(H,19,20,22) GTZGLKDMQAHUTP-UHFFFAOYSA-N 176793 US9675612, 31 [7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl](piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 188 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176793&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323716 363893428 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474638 O=C(N1CCCCC1)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C18H16N6O2S2/c25-17(24-6-2-1-3-7-24)16-23-13-14(19-9-20-15(13)28-16)21-10-4-5-11-12(8-10)27-18(26)22-11/h4-5,8-9H,1-3,6-7H2,(H,22,26)(H,19,20,21) FSGSASMAGXXRPZ-UHFFFAOYSA-N 176794 US9675612, 32 6-{[2-(Piperidin-1-ylcarbonyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 137 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176794&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323064 363893429 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474639 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C19H19N7O2S/c1-28-14-8-12-11(9-22-25-12)7-13(14)23-16-15-17(21-10-20-16)29-18(24-15)19(27)26-5-3-2-4-6-26/h7-10H,2-6H2,1H3,(H,22,25)(H,20,21,23) AUDXHTGDNOKTJE-UHFFFAOYSA-N 176795 US9675612, 33 {7-[(6-Methoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}(piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176795&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78209989 363893430 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474640 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C20H21N7O2S/c1-2-29-15-9-13-12(10-23-26-13)8-14(15)24-17-16-18(22-11-21-17)30-19(25-16)20(28)27-6-4-3-5-7-27/h8-11H,2-7H2,1H3,(H,23,26)(H,21,22,24) XXQQLBYIKZQGJQ-UHFFFAOYSA-N 176796 US9675612, 34 {7-[(6-Ethoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}(piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 34 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176796&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323065 363893431 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474641 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C21H23N7O2S/c1-12(2)30-16-9-14-13(10-24-27-14)8-15(16)25-18-17-19(23-11-22-18)31-20(26-17)21(29)28-6-4-3-5-7-28/h8-12H,3-7H2,1-2H3,(H,24,27)(H,22,23,25) IWFOIBXHQBGDSE-UHFFFAOYSA-N 176798 US9675612, 35 Piperidin-1-yl(7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidin-2-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 102 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176798&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323066 363893432 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474642 CN(C)C(=O)CN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H18N8O2S/c1-25(2)13(27)8-26(3)18(28)17-23-14-15(19-9-20-16(14)29-17)22-11-4-5-12-10(6-11)7-21-24-12/h4-7,9H,8H2,1-3H3,(H,21,24)(H,19,20,22) YENCYEMLPGOTLV-UHFFFAOYSA-N 176799 US9675612, 36 N-[2-(Dimethylamino)-2-oxoethyl]-7-(1H-indazol-5-ylamino)-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 81 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176799&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323067 363893433 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474643 CN(C)C(=O)CN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C18H17N7O3S2/c1-24(2)12(26)7-25(3)17(27)16-23-13-14(19-8-20-15(13)30-16)21-9-4-5-10-11(6-9)29-18(28)22-10/h4-6,8H,7H2,1-3H3,(H,22,28)(H,19,20,21) WPRLGOAWHDQXCW-UHFFFAOYSA-N 176800 US9675612, 37 N-[2-(Dimethylamino)-2-oxoethyl]-N-methyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 445 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176800&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323384 363893434 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474644 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C19H20N8O3S/c1-26(2)14(28)8-27(3)19(29)18-24-15-16(20-9-21-17(15)31-18)23-12-5-10-7-22-25-11(10)6-13(12)30-4/h5-7,9H,8H2,1-4H3,(H,22,25)(H,20,21,23) YUXHVQMBKVZDJF-UHFFFAOYSA-N 176801 US9675612, 38 N-[2-(Dimethylamino)-2-oxoethyl]-7-[(6-methoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 136 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176801&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323385 363893435 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474645 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C21H24N8O3S/c1-11(2)32-15-7-13-12(8-24-27-13)6-14(15)25-18-17-19(23-10-22-18)33-20(26-17)21(31)29(5)9-16(30)28(3)4/h6-8,10-11H,9H2,1-5H3,(H,24,27)(H,22,23,25) RHFZKVJUBNIYGR-UHFFFAOYSA-N 176802 US9675612, 39 N-[2-(Dimethylamino)-2-oxoethyl]-N-methyl-7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 98 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176802&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323386 363893436 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474646 CN(C)C(=O)CCN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C19H20N8O2S/c1-26(2)14(28)6-7-27(3)19(29)18-24-15-16(20-10-21-17(15)30-18)23-12-4-5-13-11(8-12)9-22-25-13/h4-5,8-10H,6-7H2,1-3H3,(H,22,25)(H,20,21,23) CFCGCECRYDIIIU-UHFFFAOYSA-N 176803 US9675612, 40 N-[3-(Dimethylamino)-3-oxopropyl]-7-(1H-indazol-5-ylamino)-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 49 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176803&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323387 363893437 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474647 CN(C)C(=O)CCN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C19H19N7O3S2/c1-25(2)13(27)6-7-26(3)18(28)17-24-14-15(20-9-21-16(14)31-17)22-10-4-5-11-12(8-10)30-19(29)23-11/h4-5,8-9H,6-7H2,1-3H3,(H,23,29)(H,20,21,22) QPOFDDVJEAKYFR-UHFFFAOYSA-N 176804 US9675612, 41 N-[3-(Dimethylamino)-3-oxopropyl]-N-methyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2750 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176804&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323389 363893438 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474648 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C21H24N8O3S/c1-5-32-15-9-13-12(10-24-27-13)8-14(15)25-18-17-19(23-11-22-18)33-20(26-17)21(31)29(4)7-6-16(30)28(2)3/h8-11H,5-7H2,1-4H3,(H,24,27)(H,22,23,25) WPIYERCLBJHUFT-UHFFFAOYSA-N 176805 US9675612, 42 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-ethoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 125 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176805&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323388 363893439 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474649 CN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C15H13N7OS/c1-22(2)15(23)14-20-11-12(16-7-17-13(11)24-14)19-9-3-4-10-8(5-9)6-18-21-10/h3-7H,1-2H3,(H,18,21)(H,16,17,19) DSGSLUOZFVMIEG-UHFFFAOYSA-N 176806 US9675612, 43 7-(1H-Indazol-5-ylamino)-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 202 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176806&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323715 363893440 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474650 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C18H19N7O2S/c1-9(2)27-13-6-11-10(7-21-24-11)5-12(13)22-15-14-16(20-8-19-15)28-17(23-14)18(26)25(3)4/h5-9H,1-4H3,(H,21,24)(H,19,20,22) GZOIWXBZLNFSOM-UHFFFAOYSA-N 176807 US9675612, 44 N,N-Dimethyl-7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 52 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176807&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323711 363893441 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474651 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C20H22N8O3S/c1-5-31-14-7-12-11(8-23-26-12)6-13(14)24-17-16-18(22-10-21-17)32-19(25-16)20(30)28(4)9-15(29)27(2)3/h6-8,10H,5,9H2,1-4H3,(H,23,26)(H,21,22,24) KDZDBRGGLATXJY-UHFFFAOYSA-N 176808 US9675612, 45 N-[2-(Dimethylamino)-2-oxoethyl]-7-[(6-ethoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 57 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176808&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323714 363893442 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474652 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C20H22N8O3S/c1-27(2)15(29)5-6-28(3)20(30)19-25-16-17(21-10-22-18(16)32-19)24-13-7-11-9-23-26-12(11)8-14(13)31-4/h7-10H,5-6H2,1-4H3,(H,23,26)(H,21,22,24) RHMWHKLMOIVTHU-UHFFFAOYSA-N 176810 US9675612, 46 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-methoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 184 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176810&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323712 363893443 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474653 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C22H26N8O3S/c1-12(2)33-16-9-14-13(10-25-28-14)8-15(16)26-19-18-20(24-11-23-19)34-21(27-18)22(32)30(5)7-6-17(31)29(3)4/h8-12H,6-7H2,1-5H3,(H,25,28)(H,23,24,26) SLXIXSQVDODQRE-UHFFFAOYSA-N 176814 US9675612, 47 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-isopropoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 32 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176814&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323713 363893444 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664327 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C22H16N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h1-13,21,27H,(H,24,25,28) QXPFEBPNDCKVSY-UHFFFAOYSA-N 337233 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-phenylacetamide::US9745304, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337233&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846997 384989288 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664326 O=C(Cc1ccccc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(12-15-6-2-1-3-7-15)24-20-10-11-21-23-14-17(26(21)25-20)19-13-16-8-4-5-9-18(16)28-19/h1-11,13-14H,12H2,(H,24,25,27) XDVBPXTUGFLXON-UHFFFAOYSA-N 337232 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-phenylacetamide::US9745304, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337232&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846996 384989287 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664328 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cccnc1 InChI=1S/C21H15N5O3/c27-20(14-5-3-9-22-11-14)21(28)24-18-7-8-19-23-12-15(26(19)25-18)17-10-13-4-1-2-6-16(13)29-17/h1-12,20,27H,(H,24,25,28) FQFWDRRIGZELJC-UHFFFAOYSA-N 337234 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(pyridin-3-yl)acetamide::US9745304, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337234&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 76900001 384989289 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664329 OC(C1CCCCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H22N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h4-5,8-14,21,27H,1-3,6-7H2,(H,24,25,28) ICCQYTQJXWVGFI-UHFFFAOYSA-N 337235 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclohexyl-2-hydroxyacetamide::US9745304, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337235&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846998 384989290 C03491 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664330 OC(C1CCOCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H20N4O4/c26-20(13-7-9-28-10-8-13)21(27)23-18-5-6-19-22-12-15(25(19)24-18)17-11-14-3-1-2-4-16(14)29-17/h1-6,11-13,20,26H,7-10H2,(H,23,24,27) PZYCUQOXELRUSR-UHFFFAOYSA-N 337236 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(tetrahydro-2H-pyran-4-yl)acetamide::US9745304, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337236&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846999 384989291 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664331 O=C(Cc1ccccn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(12-15-6-3-4-10-22-15)24-19-8-9-20-23-13-16(26(20)25-19)18-11-14-5-1-2-7-17(14)28-18/h1-11,13H,12H2,(H,24,25,27) HQFNIOFCBJTMAX-UHFFFAOYSA-N 337237 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-2-yl)acetamide::US9745304, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337237&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847000 384989292 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664332 O=C(Cc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(10-14-4-3-9-22-12-14)24-19-7-8-20-23-13-16(26(20)25-19)18-11-15-5-1-2-6-17(15)28-18/h1-9,11-13H,10H2,(H,24,25,27) IBSWPCDMBCFSGG-UHFFFAOYSA-N 337238 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-3-yl)acetamide::US9745304, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337238&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847001 384989293 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664333 Fc1cccc(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C22H15FN4O2/c23-16-6-3-4-14(10-16)11-22(28)25-20-8-9-21-24-13-17(27(21)26-20)19-12-15-5-1-2-7-18(15)29-19/h1-10,12-13H,11H2,(H,25,26,28) UJUIOOAUSDYSIL-UHFFFAOYSA-N 337239 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)-acetamide::US9745304, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337239&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847080 384989294 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664334 O=C(CCc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H17N5O2/c28-22(10-7-15-4-3-11-23-13-15)25-20-8-9-21-24-14-17(27(21)26-20)19-12-16-5-1-2-6-18(16)29-19/h1-6,8-9,11-14H,7,10H2,(H,25,26,28) DIMYYEALYLMAGB-UHFFFAOYSA-N 337240 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(pyridin-3-yl)propanamide::US9745304, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337240&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847081 384989295 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664335 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cc(=O)[nH]c(=O)[nH]1 InChI=1S/C19H12N6O4/c26-17-8-11(21-19(28)23-17)18(27)22-15-5-6-16-20-9-12(25(16)24-15)14-7-10-3-1-2-4-13(10)29-14/h1-9H,(H,22,24,27)(H2,21,23,26,28) PPWCXMBGMSTYLX-UHFFFAOYSA-N 337241 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamide::US9745304, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337241&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 138752871 384989296 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664336 OC[C@@H]1CCC(=O)N1c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-11-13-5-8-19(25)22(13)18-7-6-17-20-10-14(23(17)21-18)16-9-12-3-1-2-4-15(12)26-16/h1-4,6-7,9-10,13,24H,5,8,11H2/t13-/m0/s1 APAZAFAHWYCIQA-ZDUSSCGKSA-N 337242 (5S)-1-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-5-(hydroxymethyl)-pyrrolidin-2-one::US9745304, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337242&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847083 384989297 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664337 OC(C1CC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-18(11-5-6-11)19(25)21-16-7-8-17-20-10-13(23(17)22-16)15-9-12-3-1-2-4-14(12)26-15/h1-4,7-11,18,24H,5-6H2,(H,21,22,25) PHSFIJKQTLJRMC-UHFFFAOYSA-N 337243 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclopropyl-2-hydroxyacetamide::US9745304, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337243&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847084 384989298 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664338 C[C@@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m1/s1 ILOSUKCSYQKFFX-SNVBAGLBSA-N 337244 (2R)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337244&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847085 384989299 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664339 C[C@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m0/s1 ILOSUKCSYQKFFX-JTQLQIEISA-N 337245 (2S)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337245&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847086 384989300 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664340 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m1/s1 PJWUSWRCXKIDCP-SECBINFHSA-N 337246 (2R)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]-pyridazin-6-yl]propanamide::US9745304, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337246&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847161 384989301 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664341 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m0/s1 PJWUSWRCXKIDCP-VIFPVBQESA-N 337247 (2S)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-yl]propanamide::US9745304, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337247&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847162 384989302 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664342 CC(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-12(2)9-19(24)21-17-7-8-18-20-11-14(23(18)22-17)16-10-13-5-3-4-6-15(13)25-16/h3-8,10-12H,9H2,1-2H3,(H,21,22,24) GUZOCJQPALBFDG-UHFFFAOYSA-N 337248 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-methylbutanamide::US9745304, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337248&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847163 384989303 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664343 O=C(Cc1ccc(cc1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-7-5-15(6-8-16)11-23(29)26-21-9-10-22-25-14-18(28(22)27-21)20-12-17-3-1-2-4-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) YKEPVEZYTGZSPT-UHFFFAOYSA-N 337249 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(4-cyanophenyl)-acetamide::US9745304, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337249&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847164 384989304 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664344 O=C(CCc1c[nH]cn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H16N6O2/c27-20(8-5-14-10-21-12-23-14)24-18-6-7-19-22-11-15(26(19)25-18)17-9-13-3-1-2-4-16(13)28-17/h1-4,6-7,9-12H,5,8H2,(H,21,23)(H,24,25,27) BCIIUYDUOQBHKE-UHFFFAOYSA-N 337250 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(1H-imidazol-4-yl)-propanamide::US9745304, Example 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337250&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847165 384989305 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664345 Cn1cc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cn1 InChI=1S/C21H18N6O2/c1-26-13-14(11-23-26)6-9-21(28)24-19-7-8-20-22-12-16(27(20)25-19)18-10-15-4-2-3-5-17(15)29-18/h2-5,7-8,10-13H,6,9H2,1H3,(H,24,25,28) PAHSJNMOWPRPGR-UHFFFAOYSA-N 337251 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(1-methyl-1H-pyrazol-4- yl)propanamide::US9745304, Example 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337251&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 118599578 384989306 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664346 O=C(Cc1cccc(c1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-5-3-4-15(10-16)11-23(29)26-21-8-9-22-25-14-18(28(22)27-21)20-12-17-6-1-2-7-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) VDNSWVFOVAECEA-UHFFFAOYSA-N 337252 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(3-cyanophenyl)acetamide::US9745304, Example 21 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337252&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847247 384989307 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664347 O=C(CCC1CC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H18N4O2/c25-20(10-7-13-5-6-13)22-18-8-9-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)26-17/h1-4,8-9,11-13H,5-7,10H2,(H,22,23,25) MCALTGVZBFASBT-UHFFFAOYSA-N 337253 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-cyclopropylpropanamide::US9745304, Example 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337253&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847248 384989308 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664348 CCN(CC)CCC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H23N5O2/c1-3-25(4-2)12-11-21(27)23-19-9-10-20-22-14-16(26(20)24-19)18-13-15-7-5-6-8-17(15)28-18/h5-10,13-14H,3-4,11-12H2,1-2H3,(H,23,24,27) LJVYMGFVDGXMRC-UHFFFAOYSA-N 337254 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N3,N3-diethyl-beta-alaninamide::US9745304, Example 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337254&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847249 384989309 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664349 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1(CC1)C#N InChI=1S/C19H13N5O2/c20-11-19(7-8-19)18(25)22-16-5-6-17-21-10-13(24(17)23-16)15-9-12-3-1-2-4-14(12)26-15/h1-6,9-10H,7-8H2,(H,22,23,25) SIRRALRYLSPTEY-UHFFFAOYSA-N 337255 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 1-cyanocyclopropane carboxamide::US9745304, Example 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337255&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847250 384989310 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664350 FC(F)(F)c1ccccc1CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15F3N4O2/c24-23(25,26)16-7-3-1-5-14(16)12-22(31)28-20-9-10-21-27-13-17(30(21)29-20)19-11-15-6-2-4-8-18(15)32-19/h1-11,13H,12H2,(H,28,29,31) YZTIMMGUZXDJJP-UHFFFAOYSA-N 337256 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-[2- (trifluoromethyl)phenyl]acetamide::US9745304, Example 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 31.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337256&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847251 384989311 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664351 O=C(CC#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H11N5O2/c18-8-7-17(23)20-15-5-6-16-19-10-12(22(16)21-15)14-9-11-3-1-2-4-13(11)24-14/h1-6,9-10H,7H2,(H,20,21,23) IVOLTHFUVJXAPG-UHFFFAOYSA-N 337257 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-cyanoacetamide::US9745304, Example 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337257&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847252 384989312 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664352 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCOCC1 InChI=1S/C20H18N4O3/c25-20(13-7-9-26-10-8-13)22-18-5-6-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)27-17/h1-6,11-13H,7-10H2,(H,22,23,25) ZHKRRCTXZCUDKD-UHFFFAOYSA-N 337258 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6- yl]tetrahydro-2H-pyran-4- carboxamide::US9745304, Example 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337258&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847330 384989313 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664353 CN(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N5O2/c1-22(2)11-18(24)20-16-7-8-17-19-10-13(23(17)21-16)15-9-12-5-3-4-6-14(12)25-15/h3-10H,11H2,1-2H3,(H,20,21,24) ZNCQPBAIESXLCS-UHFFFAOYSA-N 337259 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N2,N2-dimethylglycinamide::US9745304, Example 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337259&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847331 384989314 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664354 Fc1ccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cc1 InChI=1S/C23H17FN4O2/c24-17-8-5-15(6-9-17)7-12-23(29)26-21-10-11-22-25-14-18(28(22)27-21)20-13-16-3-1-2-4-19(16)30-20/h1-6,8-11,13-14H,7,12H2,(H,26,27,29) DVKRXTYEDGWONB-UHFFFAOYSA-N 337260 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(4-fluorophenyl)propanamide::US9745304, Example 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 44.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337260&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847332 384989315 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664355 O=C(CN1CCCC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H19N5O2/c26-20(13-24-9-3-4-10-24)22-18-7-8-19-21-12-15(25(19)23-18)17-11-14-5-1-2-6-16(14)27-17/h1-2,5-8,11-12H,3-4,9-10,13H2,(H,22,23,26) RFXGQIZWLZIASR-UHFFFAOYSA-N 337261 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(pyrrolidin-1-yl)acetamide::US9745304, Example 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 30.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337261&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847333 384989316 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664356 Cc1cccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C24H20N4O2/c1-16-5-4-6-17(13-16)9-12-24(29)26-22-10-11-23-25-15-19(28(23)27-22)21-14-18-7-2-3-8-20(18)30-21/h2-8,10-11,13-15H,9,12H2,1H3,(H,26,27,29) KDJGBGJDYGZBCB-UHFFFAOYSA-N 337262 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(3-methylphenyl)propanamide::US9745304, Example 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 67.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337262&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847334 384989317 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664357 CC1CCN(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)CC1 InChI=1S/C22H23N5O2/c1-15-8-10-26(11-9-15)14-22(28)24-20-6-7-21-23-13-17(27(21)25-20)19-12-16-4-2-3-5-18(16)29-19/h2-7,12-13,15H,8-11,14H2,1H3,(H,24,25,28) QSNZOIMTTIUEHU-UHFFFAOYSA-N 337263 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(4-methylpiperidin-1- yl)acetamide::US9745304, Example 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337263&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847335 384989318 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665928 O=C(Cc1ccccc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(12-15-6-2-1-3-7-15)24-20-10-11-21-23-14-17(26(21)25-20)19-13-16-8-4-5-9-18(16)28-19/h1-11,13-14H,12H2,(H,24,25,27) XDVBPXTUGFLXON-UHFFFAOYSA-N 337232 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-phenylacetamide::US9745304, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337232&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846996 384989287 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665929 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C22H16N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h1-13,21,27H,(H,24,25,28) QXPFEBPNDCKVSY-UHFFFAOYSA-N 337233 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-phenylacetamide::US9745304, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337233&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846997 384989288 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665930 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cccnc1 InChI=1S/C21H15N5O3/c27-20(14-5-3-9-22-11-14)21(28)24-18-7-8-19-23-12-15(26(19)25-18)17-10-13-4-1-2-6-16(13)29-17/h1-12,20,27H,(H,24,25,28) FQFWDRRIGZELJC-UHFFFAOYSA-N 337234 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(pyridin-3-yl)acetamide::US9745304, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337234&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 76900001 384989289 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665931 OC(C1CCCCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H22N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h4-5,8-14,21,27H,1-3,6-7H2,(H,24,25,28) ICCQYTQJXWVGFI-UHFFFAOYSA-N 337235 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclohexyl-2-hydroxyacetamide::US9745304, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337235&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846998 384989290 C03491 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665932 OC(C1CCOCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H20N4O4/c26-20(13-7-9-28-10-8-13)21(27)23-18-5-6-19-22-12-15(25(19)24-18)17-11-14-3-1-2-4-16(14)29-17/h1-6,11-13,20,26H,7-10H2,(H,23,24,27) PZYCUQOXELRUSR-UHFFFAOYSA-N 337236 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(tetrahydro-2H-pyran-4-yl)acetamide::US9745304, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337236&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846999 384989291 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665933 O=C(Cc1ccccn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(12-15-6-3-4-10-22-15)24-19-8-9-20-23-13-16(26(20)25-19)18-11-14-5-1-2-7-17(14)28-18/h1-11,13H,12H2,(H,24,25,27) HQFNIOFCBJTMAX-UHFFFAOYSA-N 337237 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-2-yl)acetamide::US9745304, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337237&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847000 384989292 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665934 O=C(Cc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(10-14-4-3-9-22-12-14)24-19-7-8-20-23-13-16(26(20)25-19)18-11-15-5-1-2-6-17(15)28-18/h1-9,11-13H,10H2,(H,24,25,27) IBSWPCDMBCFSGG-UHFFFAOYSA-N 337238 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-3-yl)acetamide::US9745304, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337238&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847001 384989293 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665935 Fc1cccc(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C22H15FN4O2/c23-16-6-3-4-14(10-16)11-22(28)25-20-8-9-21-24-13-17(27(21)26-20)19-12-15-5-1-2-7-18(15)29-19/h1-10,12-13H,11H2,(H,25,26,28) UJUIOOAUSDYSIL-UHFFFAOYSA-N 337239 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)-acetamide::US9745304, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337239&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847080 384989294 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665936 O=C(CCc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H17N5O2/c28-22(10-7-15-4-3-11-23-13-15)25-20-8-9-21-24-14-17(27(21)26-20)19-12-16-5-1-2-6-18(16)29-19/h1-6,8-9,11-14H,7,10H2,(H,25,26,28) DIMYYEALYLMAGB-UHFFFAOYSA-N 337240 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(pyridin-3-yl)propanamide::US9745304, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337240&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847081 384989295 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665937 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cc(=O)[nH]c(=O)[nH]1 InChI=1S/C19H12N6O4/c26-17-8-11(21-19(28)23-17)18(27)22-15-5-6-16-20-9-12(25(16)24-15)14-7-10-3-1-2-4-13(10)29-14/h1-9H,(H,22,24,27)(H2,21,23,26,28) PPWCXMBGMSTYLX-UHFFFAOYSA-N 337241 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamide::US9745304, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337241&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 138752871 384989296 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665938 OC[C@@H]1CCC(=O)N1c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-11-13-5-8-19(25)22(13)18-7-6-17-20-10-14(23(17)21-18)16-9-12-3-1-2-4-15(12)26-16/h1-4,6-7,9-10,13,24H,5,8,11H2/t13-/m0/s1 APAZAFAHWYCIQA-ZDUSSCGKSA-N 337242 (5S)-1-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-5-(hydroxymethyl)-pyrrolidin-2-one::US9745304, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337242&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847083 384989297 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665939 OC(C1CC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-18(11-5-6-11)19(25)21-16-7-8-17-20-10-13(23(17)22-16)15-9-12-3-1-2-4-14(12)26-15/h1-4,7-11,18,24H,5-6H2,(H,21,22,25) PHSFIJKQTLJRMC-UHFFFAOYSA-N 337243 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclopropyl-2-hydroxyacetamide::US9745304, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337243&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847084 384989298 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665940 C[C@@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m1/s1 ILOSUKCSYQKFFX-SNVBAGLBSA-N 337244 (2R)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337244&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847085 384989299 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665941 C[C@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m0/s1 ILOSUKCSYQKFFX-JTQLQIEISA-N 337245 (2S)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337245&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847086 384989300 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665942 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m1/s1 PJWUSWRCXKIDCP-SECBINFHSA-N 337246 (2R)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]-pyridazin-6-yl]propanamide::US9745304, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337246&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847161 384989301 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665943 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m0/s1 PJWUSWRCXKIDCP-VIFPVBQESA-N 337247 (2S)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-yl]propanamide::US9745304, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337247&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847162 384989302 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665944 CC(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-12(2)9-19(24)21-17-7-8-18-20-11-14(23(18)22-17)16-10-13-5-3-4-6-15(13)25-16/h3-8,10-12H,9H2,1-2H3,(H,21,22,24) GUZOCJQPALBFDG-UHFFFAOYSA-N 337248 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-methylbutanamide::US9745304, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337248&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847163 384989303 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665945 O=C(Cc1ccc(cc1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-7-5-15(6-8-16)11-23(29)26-21-9-10-22-25-14-18(28(22)27-21)20-12-17-3-1-2-4-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) YKEPVEZYTGZSPT-UHFFFAOYSA-N 337249 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(4-cyanophenyl)-acetamide::US9745304, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337249&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847164 384989304 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665946 O=C(CCc1c[nH]cn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H16N6O2/c27-20(8-5-14-10-21-12-23-14)24-18-6-7-19-22-11-15(26(19)25-18)17-9-13-3-1-2-4-16(13)28-17/h1-4,6-7,9-12H,5,8H2,(H,21,23)(H,24,25,27) BCIIUYDUOQBHKE-UHFFFAOYSA-N 337250 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(1H-imidazol-4-yl)-propanamide::US9745304, Example 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337250&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847165 384989305 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665947 Cn1cc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cn1 InChI=1S/C21H18N6O2/c1-26-13-14(11-23-26)6-9-21(28)24-19-7-8-20-22-12-16(27(20)25-19)18-10-15-4-2-3-5-17(15)29-18/h2-5,7-8,10-13H,6,9H2,1H3,(H,24,25,28) PAHSJNMOWPRPGR-UHFFFAOYSA-N 337251 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(1-methyl-1H-pyrazol-4- yl)propanamide::US9745304, Example 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337251&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 118599578 384989306 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665948 O=C(Cc1cccc(c1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-5-3-4-15(10-16)11-23(29)26-21-8-9-22-25-14-18(28(22)27-21)20-12-17-6-1-2-7-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) VDNSWVFOVAECEA-UHFFFAOYSA-N 337252 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(3-cyanophenyl)acetamide::US9745304, Example 21 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337252&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847247 384989307 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665949 O=C(CCC1CC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H18N4O2/c25-20(10-7-13-5-6-13)22-18-8-9-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)26-17/h1-4,8-9,11-13H,5-7,10H2,(H,22,23,25) MCALTGVZBFASBT-UHFFFAOYSA-N 337253 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-cyclopropylpropanamide::US9745304, Example 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337253&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847248 384989308 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665950 CCN(CC)CCC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H23N5O2/c1-3-25(4-2)12-11-21(27)23-19-9-10-20-22-14-16(26(20)24-19)18-13-15-7-5-6-8-17(15)28-18/h5-10,13-14H,3-4,11-12H2,1-2H3,(H,23,24,27) LJVYMGFVDGXMRC-UHFFFAOYSA-N 337254 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N3,N3-diethyl-beta-alaninamide::US9745304, Example 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337254&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847249 384989309 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665951 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1(CC1)C#N InChI=1S/C19H13N5O2/c20-11-19(7-8-19)18(25)22-16-5-6-17-21-10-13(24(17)23-16)15-9-12-3-1-2-4-14(12)26-15/h1-6,9-10H,7-8H2,(H,22,23,25) SIRRALRYLSPTEY-UHFFFAOYSA-N 337255 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 1-cyanocyclopropane carboxamide::US9745304, Example 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337255&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847250 384989310 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665952 FC(F)(F)c1ccccc1CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15F3N4O2/c24-23(25,26)16-7-3-1-5-14(16)12-22(31)28-20-9-10-21-27-13-17(30(21)29-20)19-11-15-6-2-4-8-18(15)32-19/h1-11,13H,12H2,(H,28,29,31) YZTIMMGUZXDJJP-UHFFFAOYSA-N 337256 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-[2- (trifluoromethyl)phenyl]acetamide::US9745304, Example 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 31.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337256&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847251 384989311 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665953 O=C(CC#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H11N5O2/c18-8-7-17(23)20-15-5-6-16-19-10-12(22(16)21-15)14-9-11-3-1-2-4-13(11)24-14/h1-6,9-10H,7H2,(H,20,21,23) IVOLTHFUVJXAPG-UHFFFAOYSA-N 337257 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-cyanoacetamide::US9745304, Example 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337257&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847252 384989312 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665954 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCOCC1 InChI=1S/C20H18N4O3/c25-20(13-7-9-26-10-8-13)22-18-5-6-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)27-17/h1-6,11-13H,7-10H2,(H,22,23,25) ZHKRRCTXZCUDKD-UHFFFAOYSA-N 337258 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6- yl]tetrahydro-2H-pyran-4- carboxamide::US9745304, Example 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337258&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847330 384989313 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665955 CN(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N5O2/c1-22(2)11-18(24)20-16-7-8-17-19-10-13(23(17)21-16)15-9-12-5-3-4-6-14(12)25-15/h3-10H,11H2,1-2H3,(H,20,21,24) ZNCQPBAIESXLCS-UHFFFAOYSA-N 337259 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N2,N2-dimethylglycinamide::US9745304, Example 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337259&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847331 384989314 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665956 Fc1ccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cc1 InChI=1S/C23H17FN4O2/c24-17-8-5-15(6-9-17)7-12-23(29)26-21-10-11-22-25-14-18(28(22)27-21)20-13-16-3-1-2-4-19(16)30-20/h1-6,8-11,13-14H,7,12H2,(H,26,27,29) DVKRXTYEDGWONB-UHFFFAOYSA-N 337260 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(4-fluorophenyl)propanamide::US9745304, Example 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 44.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337260&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847332 384989315 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665957 O=C(CN1CCCC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H19N5O2/c26-20(13-24-9-3-4-10-24)22-18-7-8-19-21-12-15(25(19)23-18)17-11-14-5-1-2-6-16(14)27-17/h1-2,5-8,11-12H,3-4,9-10,13H2,(H,22,23,26) RFXGQIZWLZIASR-UHFFFAOYSA-N 337261 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(pyrrolidin-1-yl)acetamide::US9745304, Example 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 30.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337261&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847333 384989316 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665958 Cc1cccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C24H20N4O2/c1-16-5-4-6-17(13-16)9-12-24(29)26-22-10-11-23-25-15-19(28(23)27-22)21-14-18-7-2-3-8-20(18)30-21/h2-8,10-11,13-15H,9,12H2,1H3,(H,26,27,29) KDJGBGJDYGZBCB-UHFFFAOYSA-N 337262 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(3-methylphenyl)propanamide::US9745304, Example 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 67.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337262&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847334 384989317 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665959 CC1CCN(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)CC1 InChI=1S/C22H23N5O2/c1-15-8-10-26(11-9-15)14-22(28)24-20-6-7-21-23-13-17(27(21)25-20)19-12-16-4-2-3-5-18(16)29-19/h2-7,12-13,15H,8-11,14H2,1H3,(H,24,25,28) QSNZOIMTTIUEHU-UHFFFAOYSA-N 337263 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(4-methylpiperidin-1- yl)acetamide::US9745304, Example 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337263&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847335 384989318 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678887 C(CC1CNCCO1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-13-22-19-5-6-20(23-24(16)19)26-9-7-15-12-21-8-10-25-15/h1-6,11,13,15,21H,7-10,12H2 UDLNAUAGGZUIGC-UHFFFAOYSA-N 343673 3-(1-Benzofuran-2-yl)-6-[2-(morpholin-2-yl)ethoxy]imidazo[1,2-b]pyridazine::US9777004, 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343673&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744403 385449767 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678888 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CNCCO1 InChI=1S/C19H18N4O3/c1-2-4-16-13(3-1)9-17(26-16)15-11-21-18-5-6-19(22-23(15)18)25-12-14-10-20-7-8-24-14/h1-6,9,11,14,20H,7-8,10,12H2 VMMZJPIBWNIKLX-UHFFFAOYSA-N 343674 6-Chloro-3-(4-methoxy-1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343674&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744431 385449768 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678889 CC(C)(C)CNCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H26N4O2/c1-22(2,3)15-23-11-6-12-27-21-10-9-20-24-14-17(26(20)25-21)19-13-16-7-4-5-8-18(16)28-19/h4-5,7-10,13-14,23H,6,11-12,15H2,1-3H3 APWLCCXBHQEQCW-UHFFFAOYSA-N 343675 6-Chloro-3-(5-methoxy-1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343675&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744432 385449769 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678890 C(COc1ccc2ncc(-c3cc4ccccc4o3)n2n1)NCC1CC1 InChI=1S/C20H20N4O2/c1-2-4-17-15(3-1)11-18(26-17)16-13-22-19-7-8-20(23-24(16)19)25-10-9-21-12-14-5-6-14/h1-4,7-8,11,13-14,21H,5-6,9-10,12H2 PXZIWVGOPWSNQT-UHFFFAOYSA-N 343676 2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(cyclopropylmethyl)ethanamine::US9777004, 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343676&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744434 385449770 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678891 C(C[C@@H]1COCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-12-22-19-5-6-20(23-24(16)19)26-9-7-15-13-25-10-8-21-15/h1-6,11-12,15,21H,7-10,13H2/t15-/m1/s1 FCVZAGHPGIACKM-OAHLLOKOSA-N 343677 3-(1-Benzofuran-2-yl)-6-{2-[(3R)-morpholin-3-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343677&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744436 385449771 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678892 CC(C)NCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-14(2)21-10-5-11-25-20-9-8-19-22-13-16(24(19)23-20)18-12-15-6-3-4-7-17(15)26-18/h3-4,6-9,12-14,21H,5,10-11H2,1-2H3 BHAGDZVLGOTYEF-UHFFFAOYSA-N 343678 3-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(propan-2-yl)propan-1-amine::US9777004, 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343678&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744437 385449772 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678893 CC(C)NCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H20N4O2/c1-13(2)20-9-10-24-19-8-7-18-21-12-15(23(18)22-19)17-11-14-5-3-4-6-16(14)25-17/h3-8,11-13,20H,9-10H2,1-2H3 UFKPTPALCUPKHB-UHFFFAOYSA-N 343679 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)propan-2-amine::US9777004, 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343679&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744468 385449773 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678894 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)[C@@H]1CNCCO1 InChI=1S/C19H18N4O3/c1-2-4-16-13(3-1)9-17(26-16)15-11-21-18-5-6-19(22-23(15)18)25-12-14-10-20-7-8-24-14/h1-6,9,11,14,20H,7-8,10,12H2/t14-/m0/s1 VMMZJPIBWNIKLX-AWEZNQCLSA-N 343680 3-(1-Benzofuran-2-yl)-6-[(2S)-morpholin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343680&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744469 385449774 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678895 CC(C)(C)CNCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H24N4O2/c1-21(2,3)14-22-10-11-26-20-9-8-19-23-13-16(25(19)24-20)18-12-15-6-4-5-7-17(15)27-18/h4-9,12-13,22H,10-11,14H2,1-3H3 AQZADXSKWMQHRQ-UHFFFAOYSA-N 343681 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)-2,2-dimethylpropan-1-amine::US9777004, 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343681&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744470 385449775 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678896 C(C[C@H]1COCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-12-22-19-5-6-20(23-24(16)19)26-9-7-15-13-25-10-8-21-15/h1-6,11-12,15,21H,7-10,13H2/t15-/m0/s1 FCVZAGHPGIACKM-HNNXBMFYSA-N 343682 3-(1-Benzofuran-2-yl)-6-{2-[(3S)-morpholin-3-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343682&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744471 385449776 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678897 C(C[C@@H]1CCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O2/c1-2-6-17-14(4-1)12-18(26-17)16-13-22-19-7-8-20(23-24(16)19)25-11-9-15-5-3-10-21-15/h1-2,4,6-8,12-13,15,21H,3,5,9-11H2/t15-/m0/s1 VGEJYQNWZIZURQ-HNNXBMFYSA-N 343683 3-(1-Benzofuran-2-yl)-6-{2-[(2S)-pyrrolidin-2-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343683&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744473 385449777 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678898 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCCN1 InChI=1S/C20H20N4O2/c1-2-7-17-14(5-1)11-18(26-17)16-12-22-19-8-9-20(23-24(16)19)25-13-15-6-3-4-10-21-15/h1-2,5,7-9,11-12,15,21H,3-4,6,10,13H2 ZAKSVFQBXKOQQY-UHFFFAOYSA-N 343684 3-(1-Benzofuran-2-yl)-6-(piperidin-2-ylmethoxy)imidazo[1,2-b]pyridazine::US9777004, 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 16.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343684&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744474 385449778 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678899 C(COc1ccc2ncc(-c3cc4ccccc4o3)n2n1)NC1CC1 InChI=1S/C19H18N4O2/c1-2-4-16-13(3-1)11-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-10-9-20-14-5-6-14/h1-4,7-8,11-12,14,20H,5-6,9-10H2 NKMMVEMDLLNRAX-UHFFFAOYSA-N 343685 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)cyclopropanamine::US9777004, 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343685&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744504 385449779 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678900 CC(C)(C)NCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-20(2,3)22-10-11-25-19-9-8-18-21-13-15(24(18)23-19)17-12-14-6-4-5-7-16(14)26-17/h4-9,12-13,22H,10-11H2,1-3H3 YFTZTNOZJQSECC-UHFFFAOYSA-N 343686 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)-2-methylpropan-2-amine::US9777004, 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 24.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343686&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744505 385449780 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678901 CC(C)NCC(C)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-13(2)21-11-14(3)25-20-9-8-19-22-12-16(24(19)23-20)18-10-15-6-4-5-7-17(15)26-18/h4-10,12-14,21H,11H2,1-3H3 UZUMVKORMDCKGK-UHFFFAOYSA-N 343687 2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(propan-2-yl)propan-1-amine::US9777004, 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 16.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343687&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744506 385449781 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678902 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCN1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-11-21-18-7-8-19(22-23(15)18)24-12-14-5-3-9-20-14/h1-2,4,6-8,10-11,14,20H,3,5,9,12H2 GTGOLIIHGCZQES-UHFFFAOYSA-N 343688 3-(1-Benzofuran-2-yl)-6-[(2R)-pyrrolidin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 21::US9777004, 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343688&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78166692 385449782 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678903 C1CNCC(C1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-14-5-3-9-20-11-14/h1-2,4,6-8,10,12,14,20H,3,5,9,11H2 RPWGYRVEMVUVBG-UHFFFAOYSA-N 343689 3-(1-Benzofuran-2-yl)-6-(piperidin-3-yloxy)imidazo[1,2-b]pyridazine::US9777004, 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343689&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744509 385449783 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678904 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCN1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-11-21-18-7-8-19(22-23(15)18)24-12-14-5-3-9-20-14/h1-2,4,6-8,10-11,14,20H,3,5,9,12H2 GTGOLIIHGCZQES-UHFFFAOYSA-N 343688 3-(1-Benzofuran-2-yl)-6-[(2R)-pyrrolidin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 21::US9777004, 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343688&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78166692 385449782 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678905 Clc1ccc2oc(cc2c1)-c1cnc2ccc(OCC[C@@H]3CCCN3)nn12 InChI=1S/C20H19ClN4O2/c21-14-3-4-17-13(10-14)11-18(27-17)16-12-23-19-5-6-20(24-25(16)19)26-9-7-15-2-1-8-22-15/h3-6,10-12,15,22H,1-2,7-9H2/t15-/m0/s1 YLHUDFFIQWPVDH-HNNXBMFYSA-N 343691 3-(5-Chloro-1-benzofuran-2-yl)-6-{2-[(2S)-pyrrolidin-2-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 39.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343691&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744539 385449784 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678906 CC(C)NCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C25H24N4O2/c1-17(2)26-16-23(18-8-4-3-5-9-18)31-25-13-12-24-27-15-20(29(24)28-25)22-14-19-10-6-7-11-21(19)30-22/h3-15,17,23,26H,16H2,1-2H3 SBJBNAJREHUALC-UHFFFAOYSA-N 343692 Formic acid-N-(2-{[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)propan-2-amine (1:1)::US9777004, 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343692&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744582 385449785 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678907 CC(C)CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C26H26N4O2/c1-18(2)15-27-17-24(19-8-4-3-5-9-19)32-26-13-12-25-28-16-21(30(25)29-26)23-14-20-10-6-7-11-22(20)31-23/h3-14,16,18,24,27H,15,17H2,1-2H3 HBUJAQCESQXMAV-UHFFFAOYSA-N 343693 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)-2-methylpropan-1-amine::US9777004, 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 59.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343693&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744541 385449786 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678908 CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C23H20N4O2/c1-24-15-21(16-7-3-2-4-8-16)29-23-12-11-22-25-14-18(27(22)26-23)20-13-17-9-5-6-10-19(17)28-20/h2-14,21,24H,15H2,1H3 KEWYBDGERGQLDK-UHFFFAOYSA-N 343694 (-)-2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-methyl-2-phenylethanamine::US9777004, 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 98.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343694&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744542 385449787 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678909 CC(C)(C)CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C27H28N4O2/c1-27(2,3)18-28-17-24(19-9-5-4-6-10-19)33-26-14-13-25-29-16-21(31(25)30-26)23-15-20-11-7-8-12-22(20)32-23/h4-16,24,28H,17-18H2,1-3H3 RQYRUJJSBDADKU-UHFFFAOYSA-N 343695 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)-2,2-dimethylpropan-1-amine::US9777004, 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 227 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343695&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744543 385449788 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678910 C1C[C@H](CN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O2/c1-2-4-15-12(3-1)9-16(24-15)14-11-20-17-5-6-18(21-22(14)17)23-13-7-8-19-10-13/h1-6,9,11,13,19H,7-8,10H2/t13-/m1/s1 UTSHYKDFDYBLPT-CYBMUJFWSA-N 343696 3-(1-Benzofuran-2-yl)-6-[(3R)-pyrrolidin-3-yloxy]imidazo[1,2-b]pyridazine::US9777004, 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 22.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343696&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744577 385449789 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678911 C1CNC[C@@H](C1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-14-5-3-9-20-11-14/h1-2,4,6-8,10,12,14,20H,3,5,9,11H2/t14-/m1/s1 RPWGYRVEMVUVBG-CQSZACIVSA-N 343697 3-(1-Benzofuran-2-yl)-6-[(3R)-piperidin-3-yloxy]imidazo[1,2-b]pyridazine::US9777004, 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 28.0 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343697&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744578 385449790 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678912 Fc1cccc2oc(cc12)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H17FN4O3/c20-14-2-1-3-16-13(14)8-17(27-16)15-10-22-18-4-5-19(23-24(15)18)26-11-12-9-21-6-7-25-12/h1-5,8,10,12,21H,6-7,9,11H2/t12-/m1/s1 AUCVAYRNICRSPG-GFCCVEGCSA-N 343698 3-(4-Fluoro-1-benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]-pyridazine::US9777004, 33 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343698&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744579 385449791 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678913 Fc1ccc2oc(cc2c1)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H17FN4O3/c20-13-1-2-16-12(7-13)8-17(27-16)15-10-22-18-3-4-19(23-24(15)18)26-11-14-9-21-5-6-25-14/h1-4,7-8,10,14,21H,5-6,9,11H2/t14-/m1/s1 XZVKEWCFFKMHPW-CQSZACIVSA-N 343699 3-(5-Fluoro-1-benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]-pyridazine::US9777004, 34 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q2B27XDM aid1797232 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343699&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744580 385449792 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678914 C(CC1CNCCO1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-13-22-19-5-6-20(23-24(16)19)26-9-7-15-12-21-8-10-25-15/h1-6,11,13,15,21H,7-10,12H2 UDLNAUAGGZUIGC-UHFFFAOYSA-N 343673 3-(1-Benzofuran-2-yl)-6-[2-(morpholin-2-yl)ethoxy]imidazo[1,2-b]pyridazine::US9777004, 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343673&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744403 385449767 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678915 COc1cccc2oc(cc12)-c1cnc2ccc(OCC3CNCCO3)nn12 InChI=1S/C20H20N4O4/c1-25-16-3-2-4-17-14(16)9-18(28-17)15-11-22-19-5-6-20(23-24(15)19)27-12-13-10-21-7-8-26-13/h2-6,9,11,13,21H,7-8,10,12H2,1H3 FTQIOEQTZGNQQV-UHFFFAOYSA-N 343700 3-(1-Benzofur-2-yl)-6-chloroimidazo[1,2-b]pyridazine::US9777004, 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343700&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78166637 385449793 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678916 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CNCCO1 InChI=1S/C19H18N4O3/c1-2-4-16-13(3-1)9-17(26-16)15-11-21-18-5-6-19(22-23(15)18)25-12-14-10-20-7-8-24-14/h1-6,9,11,14,20H,7-8,10,12H2 VMMZJPIBWNIKLX-UHFFFAOYSA-N 343674 6-Chloro-3-(4-methoxy-1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343674&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744431 385449768 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678917 CC(C)(C)CNCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H26N4O2/c1-22(2,3)15-23-11-6-12-27-21-10-9-20-24-14-17(26(20)25-21)19-13-16-7-4-5-8-18(16)28-19/h4-5,7-10,13-14,23H,6,11-12,15H2,1-3H3 APWLCCXBHQEQCW-UHFFFAOYSA-N 343675 6-Chloro-3-(5-methoxy-1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343675&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744432 385449769 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678918 COc1ccc2oc(cc2c1)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C20H20N4O4/c1-25-14-2-3-17-13(8-14)9-18(28-17)16-11-22-19-4-5-20(23-24(16)19)27-12-15-10-21-6-7-26-15/h2-5,8-9,11,15,21H,6-7,10,12H2,1H3/t15-/m1/s1 BZQBRPLLVKLUBL-OAHLLOKOSA-N 343701 6-Chloro-3-(5-chloro-1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 18.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343701&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744433 385449794 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678919 C(COc1ccc2ncc(-c3cc4ccccc4o3)n2n1)NCC1CC1 InChI=1S/C20H20N4O2/c1-2-4-17-15(3-1)11-18(26-17)16-13-22-19-7-8-20(23-24(16)19)25-10-9-21-12-14-5-6-14/h1-4,7-8,11,13-14,21H,5-6,9-10,12H2 PXZIWVGOPWSNQT-UHFFFAOYSA-N 343676 2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(cyclopropylmethyl)ethanamine::US9777004, 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 18.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343676&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744434 385449770 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678920 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)[C@H]1CNCCO1 InChI=1S/C19H18N4O3/c1-2-4-16-13(3-1)9-17(26-16)15-11-21-18-5-6-19(22-23(15)18)25-12-14-10-20-7-8-24-14/h1-6,9,11,14,20H,7-8,10,12H2/t14-/m1/s1 VMMZJPIBWNIKLX-CQSZACIVSA-N 343702 3-(1-Benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 19.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343702&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744435 385449795 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678921 C(C[C@@H]1COCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-12-22-19-5-6-20(23-24(16)19)26-9-7-15-13-25-10-8-21-15/h1-6,11-12,15,21H,7-10,13H2/t15-/m1/s1 FCVZAGHPGIACKM-OAHLLOKOSA-N 343677 3-(1-Benzofuran-2-yl)-6-{2-[(3R)-morpholin-3-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 20.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343677&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744436 385449771 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678922 CC(C)NCCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-14(2)21-10-5-11-25-20-9-8-19-22-13-16(24(19)23-20)18-12-15-6-3-4-7-17(15)26-18/h3-4,6-9,12-14,21H,5,10-11H2,1-2H3 BHAGDZVLGOTYEF-UHFFFAOYSA-N 343678 3-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(propan-2-yl)propan-1-amine::US9777004, 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 20.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343678&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744437 385449772 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678923 CC(C)NCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H20N4O2/c1-13(2)20-9-10-24-19-8-7-18-21-12-15(23(18)22-19)17-11-14-5-3-4-6-16(14)25-17/h3-8,11-13,20H,9-10H2,1-2H3 UFKPTPALCUPKHB-UHFFFAOYSA-N 343679 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)propan-2-amine::US9777004, 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 23.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343679&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744468 385449773 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678924 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)[C@@H]1CNCCO1 InChI=1S/C19H18N4O3/c1-2-4-16-13(3-1)9-17(26-16)15-11-21-18-5-6-19(22-23(15)18)25-12-14-10-20-7-8-24-14/h1-6,9,11,14,20H,7-8,10,12H2/t14-/m0/s1 VMMZJPIBWNIKLX-AWEZNQCLSA-N 343680 3-(1-Benzofuran-2-yl)-6-[(2S)-morpholin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 24.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343680&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744469 385449774 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678925 CC(C)(C)CNCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H24N4O2/c1-21(2,3)14-22-10-11-26-20-9-8-19-23-13-16(25(19)24-20)18-12-15-6-4-5-7-17(15)27-18/h4-9,12-13,22H,10-11,14H2,1-3H3 AQZADXSKWMQHRQ-UHFFFAOYSA-N 343681 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)-2,2-dimethylpropan-1-amine::US9777004, 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343681&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744470 385449775 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678926 C(C[C@H]1COCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-2-4-17-14(3-1)11-18(27-17)16-12-22-19-5-6-20(23-24(16)19)26-9-7-15-13-25-10-8-21-15/h1-6,11-12,15,21H,7-10,13H2/t15-/m0/s1 FCVZAGHPGIACKM-HNNXBMFYSA-N 343682 3-(1-Benzofuran-2-yl)-6-{2-[(3S)-morpholin-3-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343682&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744471 385449776 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678927 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CNC1 InChI=1S/C18H16N4O2/c1-2-4-15-13(3-1)7-16(24-15)14-10-20-17-5-6-18(21-22(14)17)23-11-12-8-19-9-12/h1-7,10,12,19H,8-9,11H2 JEQVNHKFQGOMCX-UHFFFAOYSA-N 343703 6-(Azetidin-3-ylmethoxy)-3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazine::US9777004, 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 27.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343703&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744472 385449796 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678928 C(C[C@@H]1CCCN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O2/c1-2-6-17-14(4-1)12-18(26-17)16-13-22-19-7-8-20(23-24(16)19)25-11-9-15-5-3-10-21-15/h1-2,4,6-8,12-13,15,21H,3,5,9-11H2/t15-/m0/s1 VGEJYQNWZIZURQ-HNNXBMFYSA-N 343683 3-(1-Benzofuran-2-yl)-6-{2-[(2S)-pyrrolidin-2-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 30.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343683&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744473 385449777 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678929 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCCN1 InChI=1S/C20H20N4O2/c1-2-7-17-14(5-1)11-18(26-17)16-12-22-19-8-9-20(23-24(16)19)25-13-15-6-3-4-10-21-15/h1-2,5,7-9,11-12,15,21H,3-4,6,10,13H2 ZAKSVFQBXKOQQY-UHFFFAOYSA-N 343684 3-(1-Benzofuran-2-yl)-6-(piperidin-2-ylmethoxy)imidazo[1,2-b]pyridazine::US9777004, 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 32.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343684&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744474 385449778 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678930 C(COc1ccc2ncc(-c3cc4ccccc4o3)n2n1)NC1CC1 InChI=1S/C19H18N4O2/c1-2-4-16-13(3-1)11-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-10-9-20-14-5-6-14/h1-4,7-8,11-12,14,20H,5-6,9-10H2 NKMMVEMDLLNRAX-UHFFFAOYSA-N 343685 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)cyclopropanamine::US9777004, 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 36.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343685&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744504 385449779 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678931 CC(C)(C)NCCOc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-20(2,3)22-10-11-25-19-9-8-18-21-13-15(24(18)23-19)17-12-14-6-4-5-7-16(14)26-17/h4-9,12-13,22H,10-11H2,1-3H3 YFTZTNOZJQSECC-UHFFFAOYSA-N 343686 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}ethyl)-2-methylpropan-2-amine::US9777004, 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 37.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343686&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744505 385449780 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678932 CC(C)NCC(C)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H22N4O2/c1-13(2)21-11-14(3)25-20-9-8-19-22-12-16(24(19)23-20)18-10-15-6-4-5-7-17(15)26-18/h4-10,12-14,21H,11H2,1-3H3 UZUMVKORMDCKGK-UHFFFAOYSA-N 343687 2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-(propan-2-yl)propan-1-amine::US9777004, 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 38.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343687&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744506 385449781 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678933 Clc1ccc2oc(cc2c1)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H17ClN4O3/c20-13-1-2-16-12(7-13)8-17(27-16)15-10-22-18-3-4-19(23-24(15)18)26-11-14-9-21-5-6-25-14/h1-4,7-8,10,14,21H,5-6,9,11H2/t14-/m1/s1 POIYCPALZMAQKT-CQSZACIVSA-N 343704 3-(5-Chloro-1-benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 41.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343704&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744507 385449797 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678934 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCN1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-11-21-18-7-8-19(22-23(15)18)24-12-14-5-3-9-20-14/h1-2,4,6-8,10-11,14,20H,3,5,9,12H2 GTGOLIIHGCZQES-UHFFFAOYSA-N 343688 3-(1-Benzofuran-2-yl)-6-[(2R)-pyrrolidin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 21::US9777004, 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 44.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343688&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78166692 385449782 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678935 C1CNCC(C1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-14-5-3-9-20-11-14/h1-2,4,6-8,10,12,14,20H,3,5,9,11H2 RPWGYRVEMVUVBG-UHFFFAOYSA-N 343689 3-(1-Benzofuran-2-yl)-6-(piperidin-3-yloxy)imidazo[1,2-b]pyridazine::US9777004, 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 53.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343689&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744509 385449783 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678936 C(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCCN1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-11-21-18-7-8-19(22-23(15)18)24-12-14-5-3-9-20-14/h1-2,4,6-8,10-11,14,20H,3,5,9,12H2 GTGOLIIHGCZQES-UHFFFAOYSA-N 343688 3-(1-Benzofuran-2-yl)-6-[(2R)-pyrrolidin-2-ylmethoxy]imidazo[1,2-b]pyridazine::US9777004, 21::US9777004, 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 53.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343688&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78166692 385449782 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678937 CNC(C)COc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H18N4O2/c1-12(19-2)11-23-18-8-7-17-20-10-14(22(17)21-18)16-9-13-5-3-4-6-15(13)24-16/h3-10,12,19H,11H2,1-2H3 HWKARIYDVGKSTP-UHFFFAOYSA-N 343705 1-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-methylpropan-2-amine::US9777004, 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 55.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343705&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744538 385449798 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678938 Clc1ccc2oc(cc2c1)-c1cnc2ccc(OCC[C@@H]3CCCN3)nn12 InChI=1S/C20H19ClN4O2/c21-14-3-4-17-13(10-14)11-18(27-17)16-12-23-19-5-6-20(24-25(16)19)26-9-7-15-2-1-8-22-15/h3-6,10-12,15,22H,1-2,7-9H2/t15-/m0/s1 YLHUDFFIQWPVDH-HNNXBMFYSA-N 343691 3-(5-Chloro-1-benzofuran-2-yl)-6-{2-[(2S)-pyrrolidin-2-yl]ethoxy}imidazo[1,2-b]pyridazine::US9777004, 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 91.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343691&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744539 385449784 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678939 CNCC(C)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H18N4O2/c1-12(10-19-2)23-18-8-7-17-20-11-14(22(17)21-18)16-9-13-5-3-4-6-15(13)24-16/h3-9,11-12,19H,10H2,1-2H3 VSKGYRRDRHJZBX-UHFFFAOYSA-N 343706 2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-methylpropan-1-amine::US9777004, 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 93.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343706&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744540 385449799 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678940 CC(C)NCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C25H24N4O2/c1-17(2)26-16-23(18-8-4-3-5-9-18)31-25-13-12-24-27-15-20(29(24)28-25)22-14-19-10-6-7-11-21(19)30-22/h3-15,17,23,26H,16H2,1-2H3 SBJBNAJREHUALC-UHFFFAOYSA-N 343692 Formic acid-N-(2-{[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)propan-2-amine (1:1)::US9777004, 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 75.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343692&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744582 385449785 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678941 CC(C)CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C26H26N4O2/c1-18(2)15-27-17-24(19-8-4-3-5-9-19)32-26-13-12-25-28-16-21(30(25)29-26)23-14-20-10-6-7-11-22(20)31-23/h3-14,16,18,24,27H,15,17H2,1-2H3 HBUJAQCESQXMAV-UHFFFAOYSA-N 343693 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)-2-methylpropan-1-amine::US9777004, 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 114 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343693&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744541 385449786 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678942 CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C23H20N4O2/c1-24-15-21(16-7-3-2-4-8-16)29-23-12-11-22-25-14-18(27(22)26-23)20-13-17-9-5-6-10-19(17)28-20/h2-14,21,24H,15H2,1H3 KEWYBDGERGQLDK-UHFFFAOYSA-N 343694 (-)-2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-N-methyl-2-phenylethanamine::US9777004, 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 124 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343694&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744542 385449787 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678943 CC(C)(C)CNCC(Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C27H28N4O2/c1-27(2,3)18-28-17-24(19-9-5-4-6-10-19)33-26-14-13-25-29-16-21(31(25)30-26)23-15-20-11-7-8-12-22(20)32-23/h4-16,24,28H,17-18H2,1-3H3 RQYRUJJSBDADKU-UHFFFAOYSA-N 343695 N-(2-{[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-phenylethyl)-2,2-dimethylpropan-1-amine::US9777004, 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 239 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343695&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744543 385449788 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678944 C1C[C@H](CN1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O2/c1-2-4-15-12(3-1)9-16(24-15)14-11-20-17-5-6-18(21-22(14)17)23-13-7-8-19-10-13/h1-6,9,11,13,19H,7-8,10H2/t13-/m1/s1 UTSHYKDFDYBLPT-CYBMUJFWSA-N 343696 3-(1-Benzofuran-2-yl)-6-[(3R)-pyrrolidin-3-yloxy]imidazo[1,2-b]pyridazine::US9777004, 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 49.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343696&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744577 385449789 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678945 C1CNC[C@@H](C1)Oc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-2-6-16-13(4-1)10-17(25-16)15-12-21-18-7-8-19(22-23(15)18)24-14-5-3-9-20-11-14/h1-2,4,6-8,10,12,14,20H,3,5,9,11H2/t14-/m1/s1 RPWGYRVEMVUVBG-CQSZACIVSA-N 343697 3-(1-Benzofuran-2-yl)-6-[(3R)-piperidin-3-yloxy]imidazo[1,2-b]pyridazine::US9777004, 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 53.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343697&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744578 385449790 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678946 Fc1cccc2oc(cc12)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H17FN4O3/c20-14-2-1-3-16-13(14)8-17(27-16)15-10-22-18-4-5-19(23-24(15)18)26-11-12-9-21-6-7-25-12/h1-5,8,10,12,21H,6-7,9,11H2/t12-/m1/s1 AUCVAYRNICRSPG-GFCCVEGCSA-N 343698 3-(4-Fluoro-1-benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]-pyridazine::US9777004, 33 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343698&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744579 385449791 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 678947 Fc1ccc2oc(cc2c1)-c1cnc2ccc(OC[C@H]3CNCCO3)nn12 InChI=1S/C19H17FN4O3/c20-13-1-2-16-12(7-13)8-17(27-16)15-10-22-18-3-4-19(23-24(15)18)26-11-14-9-21-5-6-25-14/h1-4,7-8,10,14,21H,5-6,9,11H2/t14-/m1/s1 XZVKEWCFFKMHPW-CQSZACIVSA-N 343699 3-(5-Fluoro-1-benzofuran-2-yl)-6-[(2R)-morpholin-2-ylmethoxy]imidazo[1,2-b]-pyridazine::US9777004, 34 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q2B27XDM aid1797233 US9777004 Eis, K; Puehler, F; Zorn, L; Schulze, V; Sulzle, D; Lienau, P; Hagebarth, A; Petersen, K; Bomer, U Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=343699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=343699&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 71744580 385449792 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844072 CN(C)C(=O)C1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C20H20N6OS/c1-25(2)20(27)12-3-4-15-16(9-12)28-19-17(15)18(21-11-22-19)24-13-6-8-26-14(10-13)5-7-23-26/h5-8,10-12H,3-4,9H2,1-2H3,(H,21,22,24) RCODDKVSJSBALH-UHFFFAOYSA-N 420066 (RS) N,N-Dimethyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 64.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420066&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844073 CCOC(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C20H19N5O2S/c1-2-27-20(26)12-3-4-15-16(9-12)28-19-17(15)18(21-11-22-19)24-13-6-8-25-14(10-13)5-7-23-25/h5-8,10-12H,2-4,9H2,1H3,(H,21,22,24)/t12-/m0/s1 FIXNEYABSIBKNM-LBPRGKRZSA-N 420070 (7S)-4-(Pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxylic acid::US10487092, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 707 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420070&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844074 C[C@@H]1COCCN1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H24N6O2S/c1-14-12-31-9-8-28(14)23(30)15-2-3-18-19(10-15)32-22-20(18)21(24-13-25-22)27-16-5-7-29-17(11-16)4-6-26-29/h4-7,11,13-15H,2-3,8-10,12H2,1H3,(H,24,25,27)/t14-,15+/m1/s1 PPDKIMXZIDIDTN-CABCVRRESA-N 420076 US10487092, Example 3::[(3R)-3-Methylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 80.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420076&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844075 CN(C)CCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H27N7OS/c1-28(2)10-11-29(3)23(31)15-4-5-18-19(12-15)32-22-20(18)21(24-14-25-22)27-16-7-9-30-17(13-16)6-8-26-30/h6-9,13-15H,4-5,10-12H2,1-3H3,(H,24,25,27)/t15-/m0/s1 STOQQLPSNHSISE-HNNXBMFYSA-N 420079 (7S)—N-[2-(Dimethylamino)ethyl]-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420079&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844076 C[C@H]1CN(C[C@@H](C)O1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H26N6O2S/c1-14-11-29(12-15(2)32-14)24(31)16-3-4-19-20(9-16)33-23-21(19)22(25-13-26-23)28-17-6-8-30-18(10-17)5-7-27-30/h5-8,10,13-16H,3-4,9,11-12H2,1-2H3,(H,25,26,28)/t14-,15+,16-/m0/s1 YCKBDCDXDMKTHD-XHSDSOJGSA-N 420080 US10487092, Example 5::[(2R,6S)-2,6-Dimethylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420080&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844077 CN(C)[C@@H]1CCN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H27N7OS/c1-29(2)18-7-9-30(13-18)24(32)15-3-4-19-20(11-15)33-23-21(19)22(25-14-26-23)28-16-6-10-31-17(12-16)5-8-27-31/h5-6,8,10,12,14-15,18H,3-4,7,9,11,13H2,1-2H3,(H,25,26,28)/t15-,18+/m0/s1 YNZLRXOJWFYQRP-MAUKXSAKSA-N 420085 US10487092, Example 6::[(3R)-3-(Dimethylamino)pyrrolidin-1-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420085&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844078 C[C@H]1COCCN1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H24N6O2S/c1-14-12-31-9-8-28(14)23(30)15-2-3-18-19(10-15)32-22-20(18)21(24-13-25-22)27-16-5-7-29-17(11-16)4-6-26-29/h4-7,11,13-15H,2-3,8-10,12H2,1H3,(H,24,25,27)/t14-,15-/m0/s1 PPDKIMXZIDIDTN-GJZGRUSLSA-N 420086 US10487092, Example 7::[(3S)-3-Methylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 65.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420086&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844079 COCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C22H24N6O2S/c1-27(9-10-30-2)22(29)14-3-4-17-18(11-14)31-21-19(17)20(23-13-24-21)26-15-6-8-28-16(12-15)5-7-25-28/h5-8,12-14H,3-4,9-11H2,1-2H3,(H,23,24,26)/t14-/m0/s1 RZINMLOOGJWXKZ-AWEZNQCLSA-N 420088 (7S)—N-(2-Methoxyethyl)-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 42.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420088&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844080 C[C@H]1CN(C[C@H](C)O1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H26N6O2S/c1-14-11-29(12-15(2)32-14)24(31)16-3-4-19-20(9-16)33-23-21(19)22(25-13-26-23)28-17-6-8-30-18(10-17)5-7-27-30/h5-8,10,13-16H,3-4,9,11-12H2,1-2H3,(H,25,26,28)/t14-,15-,16-/m0/s1 YCKBDCDXDMKTHD-JYJNAYRXSA-N 420089 US10487092, Example 9::[(2S,6S)-2,6-Dimethylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 49.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420089&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844081 C[C@@H]1CN(C[C@@H](C)O1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H26N6O2S/c1-14-11-29(12-15(2)32-14)24(31)16-3-4-19-20(9-16)33-23-21(19)22(25-13-26-23)28-17-6-8-30-18(10-17)5-7-27-30/h5-8,10,13-16H,3-4,9,11-12H2,1-2H3,(H,25,26,28)/t14-,15-,16+/m1/s1 YCKBDCDXDMKTHD-OAGGEKHMSA-N 420092 US10487092, Example 10::[(2R,6R)-2,6-Dimethylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 33.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420092&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844082 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CCOCC1 InChI=1S/C22H22N6O2S/c29-22(27-7-9-30-10-8-27)14-1-2-17-18(11-14)31-21-19(17)20(23-13-24-21)26-15-4-6-28-16(12-15)3-5-25-28/h3-6,12-14H,1-2,7-11H2,(H,23,24,26)/t14-/m0/s1 ONBNEGHKLYCASD-AWEZNQCLSA-N 420093 Morpholin-4-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 62.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420093&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844083 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CC2CC2C1 InChI=1S/C23H22N6OS/c30-23(28-10-14-7-15(14)11-28)13-1-2-18-19(8-13)31-22-20(18)21(24-12-25-22)27-16-4-6-29-17(9-16)3-5-26-29/h3-6,9,12-15H,1-2,7-8,10-11H2,(H,24,25,27)/t13-,14?,15?/m0/s1 NFXVKYJGNPONDN-NFOMZHRRSA-N 420094 3-Azabicyclo[3.1.0]hex-3-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 24.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420094&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844084 C[C@H]1COC[C@@H](C)N1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H26N6O2S/c1-14-11-32-12-15(2)30(14)24(31)16-3-4-19-20(9-16)33-23-21(19)22(25-13-26-23)28-17-6-8-29-18(10-17)5-7-27-29/h5-8,10,13-16H,3-4,9,11-12H2,1-2H3,(H,25,26,28)/t14-,15+,16-/m0/s1 VXEVFCGLVNWCJI-XHSDSOJGSA-N 420098 US10487092, Example 13::[(3R,5S)-3,5-Dimethylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 17.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420098&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844085 C[C@@H]1COC[C@@H](C)N1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H26N6O2S/c1-14-11-32-12-15(2)30(14)24(31)16-3-4-19-20(9-16)33-23-21(19)22(25-13-26-23)28-17-6-8-29-18(10-17)5-7-27-29/h5-8,10,13-16H,3-4,9,11-12H2,1-2H3,(H,25,26,28)/t14-,15-,16+/m1/s1 VXEVFCGLVNWCJI-OAGGEKHMSA-N 420100 US10487092, Example 14::[(3R,5R)-3,5-Dimethylmorpholin-4-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420100&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844086 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)C InChI=1S/C21H22N6O2S/c1-26(2)21(28)12-4-5-14-17(8-12)30-20-18(14)19(22-11-23-20)25-15-9-13-6-7-24-27(13)10-16(15)29-3/h6-7,9-12H,4-5,8H2,1-3H3,(H,22,23,25)/t12-/m0/s1 HGJRNYLCDLBCIK-LBPRGKRZSA-N 420101 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N,N-dimethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420101&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844087 CC(C)N(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C22H24N6OS/c1-13(2)27(3)22(29)14-4-5-17-18(10-14)30-21-19(17)20(23-12-24-21)26-15-7-9-28-16(11-15)6-8-25-28/h6-9,11-14H,4-5,10H2,1-3H3,(H,23,24,26)/t14-/m0/s1 WZSHRPNQJJAYKA-AWEZNQCLSA-N 420102 (7S)—N-Isopropyl-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 19.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420102&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844088 CN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C20H20N6OS/c1-25(2)20(27)12-3-4-15-16(9-12)28-19-17(15)18(21-11-22-19)24-13-6-8-26-14(10-13)5-7-23-26/h5-8,10-12H,3-4,9H2,1-2H3,(H,21,22,24)/t12-/m0/s1 RCODDKVSJSBALH-LBPRGKRZSA-N 420105 (7S)—N,N-Dimethyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 33.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420105&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844089 CN(CC(F)F)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C21H20F2N6OS/c1-28(10-17(22)23)21(30)12-2-3-15-16(8-12)31-20-18(15)19(24-11-25-20)27-13-5-7-29-14(9-13)4-6-26-29/h4-7,9,11-12,17H,2-3,8,10H2,1H3,(H,24,25,27)/t12-/m0/s1 LXRZRRBMNAJBFS-LBPRGKRZSA-N 420106 (7S)—N-(2,2-Difluoroethyl)-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 19.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420106&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844090 CN(CC(C)(C)O)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H26N6O2S/c1-23(2,31)12-28(3)22(30)14-4-5-17-18(10-14)32-21-19(17)20(24-13-25-21)27-15-7-9-29-16(11-15)6-8-26-29/h6-9,11,13-14,31H,4-5,10,12H2,1-3H3,(H,24,25,27)/t14-/m0/s1 IRYRYHGFOPXVDT-AWEZNQCLSA-N 420108 (7S)—N-(2-Hydroxy-2-methylpropyl)-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420108&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844091 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CCC1 InChI=1S/C21H20N6OS/c28-21(26-7-1-8-26)13-2-3-16-17(10-13)29-20-18(16)19(22-12-23-20)25-14-5-9-27-15(11-14)4-6-24-27/h4-6,9,11-13H,1-3,7-8,10H2,(H,22,23,25)/t13-/m0/s1 XUKTWRHMQXOAKH-ZDUSSCGKSA-N 420109 Azetidin-1-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 26.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420109&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844092 CCN(CCO)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C22H24N6O2S/c1-2-27(9-10-29)22(30)14-3-4-17-18(11-14)31-21-19(17)20(23-13-24-21)26-15-6-8-28-16(12-15)5-7-25-28/h5-8,12-14,29H,2-4,9-11H2,1H3,(H,23,24,26)/t14-/m0/s1 XWTFZOYEDOBRIQ-AWEZNQCLSA-N 420110 (7S)—N-Ethyl-N-(2-hydroxyethyl)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 21 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 19.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420110&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844093 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CC(C1)C#N InChI=1S/C22H19N7OS/c23-9-13-10-28(11-13)22(30)14-1-2-17-18(7-14)31-21-19(17)20(24-12-25-21)27-15-4-6-29-16(8-15)3-5-26-29/h3-6,8,12-14H,1-2,7,10-11H2,(H,24,25,27)/t14-/m0/s1 ZAVJXXCIPBNASD-AWEZNQCLSA-N 420112 1-{[(7S)-4-(Pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]carbonyl}azetidine-3-carbonitrile::US10487092, Example 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420112&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844094 FC1(F)CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C21H18F2N6OS/c22-21(23)9-28(10-21)20(30)12-1-2-15-16(7-12)31-19-17(15)18(24-11-25-19)27-13-4-6-29-14(8-13)3-5-26-29/h3-6,8,11-12H,1-2,7,9-10H2,(H,24,25,27)/t12-/m0/s1 XHZALQVDKHZOBJ-LBPRGKRZSA-N 420114 (3,3-Difluoroazetidin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 23.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420114&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844095 OC1CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C21H20N6O2S/c28-15-9-26(10-15)21(29)12-1-2-16-17(7-12)30-20-18(16)19(22-11-23-20)25-13-4-6-27-14(8-13)3-5-24-27/h3-6,8,11-12,15,28H,1-2,7,9-10H2,(H,22,23,25)/t12-/m0/s1 CXBCBEZJGMTOGK-LBPRGKRZSA-N 420115 (3-Hydroxyazetidin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 20.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420115&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844096 CN(CCNC(=O)OC(C)(C)C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C26H31N7O3S/c1-26(2,3)36-25(35)27-10-12-32(4)24(34)16-5-6-19-20(13-16)37-23-21(19)22(28-15-29-23)31-17-8-11-33-18(14-17)7-9-30-33/h7-9,11,14-16H,5-6,10,12-13H2,1-4H3,(H,27,35)(H,28,29,31)/t16-/m0/s1 SAYKEECVOQJGAA-INIZCTEOSA-N 420116 US10487092, Example 25::US10487092, Example 39::tert-Butyl [2-(methyl{[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]carbonyl}amino)ethyl]carbamate Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420116&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844097 CN(C)C(=O)CN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H25N7O2S/c1-28(2)19(31)12-29(3)23(32)14-4-5-17-18(10-14)33-22-20(17)21(24-13-25-22)27-15-7-9-30-16(11-15)6-8-26-30/h6-9,11,13-14H,4-5,10,12H2,1-3H3,(H,24,25,27)/t14-/m0/s1 FWWKQTDPTHUDMX-AWEZNQCLSA-N 420117 (7S)—N-[2-(Dimethylamino)-2-oxoethyl]-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420117&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844098 CN(C)CCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H29N7OS/c1-29(2)10-4-11-30(3)24(32)16-5-6-19-20(13-16)33-23-21(19)22(25-15-26-23)28-17-8-12-31-18(14-17)7-9-27-31/h7-9,12,14-16H,4-6,10-11,13H2,1-3H3,(H,25,26,28)/t16-/m0/s1 HBCFBKCEBSYYGX-INIZCTEOSA-N 420118 (7S)—N-[3-(Dimethylamino)propyl]-N-methyl-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420118&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844099 CN(C)C1CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H25N7OS/c1-28(2)17-11-29(12-17)23(31)14-3-4-18-19(9-14)32-22-20(18)21(24-13-25-22)27-15-6-8-30-16(10-15)5-7-26-30/h5-8,10,13-14,17H,3-4,9,11-12H2,1-2H3,(H,24,25,27)/t14-/m0/s1 XTAPEWGPISOAGQ-AWEZNQCLSA-N 420119 US10487092, Example 28::[3-(Dimethylamino)azetidin-1-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 19.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420119&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844100 CN1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C23H25N7OS/c1-28-8-10-29(11-9-28)23(31)15-2-3-18-19(12-15)32-22-20(18)21(24-14-25-22)27-16-5-7-30-17(13-16)4-6-26-30/h4-7,13-15H,2-3,8-12H2,1H3,(H,24,25,27)/t15-/m0/s1 WSKSJMPGQQFVQK-HNNXBMFYSA-N 420121 (4-Methylpiperazin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 20.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420121&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844101 CC1(O)CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C22H22N6O2S/c1-22(30)10-27(11-22)21(29)13-2-3-16-17(8-13)31-20-18(16)19(23-12-24-20)26-14-5-7-28-15(9-14)4-6-25-28/h4-7,9,12-13,30H,2-3,8,10-11H2,1H3,(H,23,24,26)/t13-/m0/s1 QKPMGSUIBUMGKZ-ZDUSSCGKSA-N 420123 (3-Hydroxy-3-methylazetidin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 16.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420123&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844102 CN(C)CCN1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C26H32N8OS/c1-31(2)9-10-32-11-13-33(14-12-32)26(35)18-3-4-21-22(15-18)36-25-23(21)24(27-17-28-25)30-19-6-8-34-20(16-19)5-7-29-34/h5-8,16-18H,3-4,9-15H2,1-2H3,(H,27,28,30)/t18-/m0/s1 LCBOCANJPSMLHD-SFHVURJKSA-N 420124 US10487092, Example 31::{4-[2-(Dimethylamino)ethyl]piperazin-1-yl}[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 26.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420124&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844103 CN(C)C1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C25H29N7OS/c1-30(2)18-7-10-31(11-8-18)25(33)16-3-4-20-21(13-16)34-24-22(20)23(26-15-27-24)29-17-6-12-32-19(14-17)5-9-28-32/h5-6,9,12,14-16,18H,3-4,7-8,10-11,13H2,1-2H3,(H,26,27,29)/t16-/m0/s1 CATNXPDRAIRDCL-INIZCTEOSA-N 420125 US10487092, Example 32::[4-(Dimethylamino)piperidin-1-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420125&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844104 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CCC(=O)CC1 InChI=1S/C23H22N6O2S/c30-17-5-8-28(9-6-17)23(31)14-1-2-18-19(11-14)32-22-20(18)21(24-13-25-22)27-15-4-10-29-16(12-15)3-7-26-29/h3-4,7,10,12-14H,1-2,5-6,8-9,11H2,(H,24,25,27)/t14-/m0/s1 JKGSLUOPUNBGQM-AWEZNQCLSA-N 420126 1-{[(7S)-4-(Pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]carbonyl}piperidin-4-one::US10487092, Example 33 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 96.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420126&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844105 FC1(F)CCN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C22H20F2N6OS/c23-22(24)5-8-29(11-22)21(31)13-1-2-16-17(9-13)32-20-18(16)19(25-12-26-20)28-14-4-7-30-15(10-14)3-6-27-30/h3-4,6-7,10,12-13H,1-2,5,8-9,11H2,(H,25,26,28)/t13-/m0/s1 MYJYYWDIECEUAY-ZDUSSCGKSA-N 420127 (3,3-Difluoropyrrolidin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 34 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 71.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420127&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844106 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1CC2(COC2)C1 InChI=1S/C23H22N6O2S/c30-22(28-9-23(10-28)11-31-12-23)14-1-2-17-18(7-14)32-21-19(17)20(24-13-25-21)27-15-4-6-29-16(8-15)3-5-26-29/h3-6,8,13-14H,1-2,7,9-12H2,(H,24,25,27)/t14-/m0/s1 ZGJKGAVBGYSYQF-AWEZNQCLSA-N 420128 2-Oxa-6-azaspiro[3.3]hept-6-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 35 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 75.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420128&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844107 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1C[C@@H]2C[C@H]1CO2 InChI=1S/C23H22N6O2S/c30-23(28-10-17-9-16(28)11-31-17)13-1-2-18-19(7-13)32-22-20(18)21(24-12-25-22)27-14-4-6-29-15(8-14)3-5-26-29/h3-6,8,12-13,16-17H,1-2,7,9-11H2,(H,24,25,27)/t13-,16-,17-/m0/s1 BZZSAKHWUSWLSE-JQFCIGGWSA-N 420129 (1S,4S)-2-Oxa-5-azabicyclo[2.2.1]hept-5-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 36 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 91.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420129&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844108 O=C([C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21)N1C[C@H]2C[C@@H]1CO2 InChI=1S/C23H22N6O2S/c30-23(28-10-17-9-16(28)11-31-17)13-1-2-18-19(7-13)32-22-20(18)21(24-12-25-22)27-14-4-6-29-15(8-14)3-5-26-29/h3-6,8,12-13,16-17H,1-2,7,9-11H2,(H,24,25,27)/t13-,16+,17+/m0/s1 BZZSAKHWUSWLSE-IAOVAPTHSA-N 420130 (1R,4R)-2-Oxa-5-azabicyclo[2.2.1]hept-5-yl[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 37 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 56.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420130&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844109 CN1C[C@@H]2C[C@H]1CN2C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H25N7OS/c1-29-11-18-10-17(29)12-30(18)24(32)14-2-3-19-20(8-14)33-23-21(19)22(25-13-26-23)28-15-5-7-31-16(9-15)4-6-27-31/h4-7,9,13-14,17-18H,2-3,8,10-12H2,1H3,(H,25,26,28)/t14-,17-,18-/m0/s1 SILWCCDCXANCHJ-WBAXXEDZSA-N 420131 US10487092, Example 38::[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 25.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420131&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844110 CN(CCNC(=O)OC(C)(C)C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C26H31N7O3S/c1-26(2,3)36-25(35)27-10-12-32(4)24(34)16-5-6-19-20(13-16)37-23-21(19)22(28-15-29-23)31-17-8-11-33-18(14-17)7-9-30-33/h7-9,11,14-16H,5-6,10,12-13H2,1-4H3,(H,27,35)(H,28,29,31)/t16-/m0/s1 SAYKEECVOQJGAA-INIZCTEOSA-N 420116 US10487092, Example 25::US10487092, Example 39::tert-Butyl [2-(methyl{[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]carbonyl}amino)ethyl]carbamate Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 41.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420116&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844111 CN(C)CCN(C)C1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C28H36N8OS/c1-33(2)14-15-34(3)21-8-11-35(12-9-21)28(37)19-4-5-23-24(16-19)38-27-25(23)26(29-18-30-27)32-20-7-13-36-22(17-20)6-10-31-36/h6-7,10,13,17-19,21H,4-5,8-9,11-12,14-16H2,1-3H3,(H,29,30,32)/t19-/m0/s1 XJVYEWNWRRHFGB-IBGZPJMESA-N 420133 (4-{[2-(Dimethylamino)ethyl](methyl)amino}piperidin-1-yl)[(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone::US10487092, Example 40 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420133&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844112 CN(C)[C@H]1CCN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H27N7OS/c1-29(2)18-7-9-30(13-18)24(32)15-3-4-19-20(11-15)33-23-21(19)22(25-14-26-23)28-16-6-10-31-17(12-16)5-8-27-31/h5-6,8,10,12,14-15,18H,3-4,7,9,11,13H2,1-2H3,(H,25,26,28)/t15-,18-/m0/s1 YNZLRXOJWFYQRP-YJBOKZPZSA-N 420134 US10487092, Example 41::[(3S)-3-(Dimethylamino)pyrrolidin-1-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420134&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844113 CN1C[C@H]2C[C@@H]1CN2C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3ccn4nccc4c3)c21 InChI=1S/C24H25N7OS/c1-29-11-18-10-17(29)12-30(18)24(32)14-2-3-19-20(8-14)33-23-21(19)22(25-13-26-23)28-15-5-7-31-16(9-15)4-6-27-31/h4-7,9,13-14,17-18H,2-3,8,10-12H2,1H3,(H,25,26,28)/t14-,17+,18+/m0/s1 SILWCCDCXANCHJ-BMGDILEWSA-N 420135 US10487092, Example 42::[(1R,4R)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl][(7S)-4-(pyrazolo[1,5-a]pyridin-5-ylamino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl]methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420135&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844114 FC(F)(F)CCNC(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C21H18ClF3N6OS/c22-14-9-31-12(3-5-29-31)8-15(14)30-18-17-13-2-1-11(19(32)26-6-4-21(23,24)25)7-16(13)33-20(17)28-10-27-18/h3,5,8-11H,1-2,4,6-7H2,(H,26,32)(H,27,28,30)/t11-/m0/s1 LXLURYCJCFLKOS-NSHDSACASA-N 420136 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-(3,3,3-trifluoropropyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 43 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 35.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420136&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844115 CC(C)NC(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C21H21ClN6OS/c1-11(2)26-20(29)12-3-4-14-17(7-12)30-21-18(14)19(23-10-24-21)27-16-8-13-5-6-25-28(13)9-15(16)22/h5-6,8-12H,3-4,7H2,1-2H3,(H,26,29)(H,23,24,27)/t12-/m0/s1 VXJZORQTLCOGET-LBPRGKRZSA-N 420137 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-(propan-2-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 44 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 54.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420137&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844116 CN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C20H19ClN6OS/c1-26(2)20(28)11-3-4-13-16(7-11)29-19-17(13)18(22-10-23-19)25-15-8-12-5-6-24-27(12)9-14(15)21/h5-6,8-11H,3-4,7H2,1-2H3,(H,22,23,25)/t11-/m0/s1 ZKRNWQNSUFKJPQ-NSHDSACASA-N 420138 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N,N-dimethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 45 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420138&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844117 CCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C21H21ClN6OS/c1-3-27(2)21(29)12-4-5-14-17(8-12)30-20-18(14)19(23-11-24-20)26-16-9-13-6-7-25-28(13)10-15(16)22/h6-7,9-12H,3-5,8H2,1-2H3,(H,23,24,26)/t12-/m0/s1 BUMCEISPKYJCGT-LBPRGKRZSA-N 420139 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-ethyl-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 46 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420139&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844118 CN(CC(F)F)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C21H19ClF2N6OS/c1-29(9-17(23)24)21(31)11-2-3-13-16(6-11)32-20-18(13)19(25-10-26-20)28-15-7-12-4-5-27-30(12)8-14(15)22/h4-5,7-8,10-11,17H,2-3,6,9H2,1H3,(H,25,26,28)/t11-/m0/s1 KGQPFBGJPIPAGJ-NSHDSACASA-N 420140 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-(2,2-difluoroethyl)-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 47 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 18.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420140&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844119 CN(CCC(F)(F)F)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H20ClF3N6OS/c1-31(7-5-22(24,25)26)21(33)12-2-3-14-17(8-12)34-20-18(14)19(27-11-28-20)30-16-9-13-4-6-29-32(13)10-15(16)23/h4,6,9-12H,2-3,5,7-8H2,1H3,(H,27,28,30)/t12-/m0/s1 PKKVWMJADOMZRX-LBPRGKRZSA-N 420141 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-N-(3,3,3-trifluoropropyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 48 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 35.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420141&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844120 CCCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H25ClN6OS/c1-3-4-9-29(2)23(31)14-5-6-16-19(10-14)32-22-20(16)21(25-13-26-22)28-18-11-15-7-8-27-30(15)12-17(18)24/h7-8,11-14H,3-6,9-10H2,1-2H3,(H,25,26,28)/t14-/m0/s1 ZMGAXTSBUWVMMH-AWEZNQCLSA-N 420142 (7S)—N-Butyl-4-[(6-chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 49 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420142&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844121 Clc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC(C1)C#N InChI=1S/C22H18ClN7OS/c23-16-10-30-14(3-4-27-30)6-17(16)28-20-19-15-2-1-13(22(31)29-8-12(7-24)9-29)5-18(15)32-21(19)26-11-25-20/h3-4,6,10-13H,1-2,5,8-9H2,(H,25,26,28)/t13-/m0/s1 RKONIKUJKULEJG-ZDUSSCGKSA-N 420143 1-((7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylcarbonyl)azetidine-3-carbonitrile::US10487092, Example 50 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420143&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844122 CN(C)CCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H28ClN7OS/c1-30(2)9-4-10-31(3)24(33)15-5-6-17-20(11-15)34-23-21(17)22(26-14-27-23)29-19-12-16-7-8-28-32(16)13-18(19)25/h7-8,12-15H,4-6,9-11H2,1-3H3,(H,26,27,29)/t15-/m0/s1 HQVOWTRRFVYHEB-HNNXBMFYSA-N 420144 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-[3-(dimethylamino)propyl]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 51 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420144&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844123 CC1(O)CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H21ClN6O2S/c1-22(31)9-28(10-22)21(30)12-2-3-14-17(6-12)32-20-18(14)19(24-11-25-20)27-16-7-13-4-5-26-29(13)8-15(16)23/h4-5,7-8,11-12,31H,2-3,6,9-10H2,1H3,(H,24,25,27)/t12-/m0/s1 NOZFPUQFJLKIBS-LBPRGKRZSA-N 420145 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl(3-hydroxy-3-methylazetidin-1-yl)methanone::US10487092, Example 52 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420145&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844124 CN(C)CCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H26ClN7OS/c1-29(2)8-9-30(3)23(32)14-4-5-16-19(10-14)33-22-20(16)21(25-13-26-22)28-18-11-15-6-7-27-31(15)12-17(18)24/h6-7,11-14H,4-5,8-10H2,1-3H3,(H,25,26,28)/t14-/m0/s1 QVOJKNKLERRTAF-AWEZNQCLSA-N 420146 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-[2-(dimethylamino)ethyl]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 53::US10487092, Example 62 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 9.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420146&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844125 CN(C)C1CN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H24ClN7OS/c1-29(2)15-9-30(10-15)23(32)13-3-4-16-19(7-13)33-22-20(16)21(25-12-26-22)28-18-8-14-5-6-27-31(14)11-17(18)24/h5-6,8,11-13,15H,3-4,7,9-10H2,1-2H3,(H,25,26,28)/t13-/m0/s1 WISBSIXKDKZASV-ZDUSSCGKSA-N 420147 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[3-(dimethylamino)azetidin-1-yl]methanone::US10487092, Example 54 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 11.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420147&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844126 CN(CCO)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C21H21ClN6O2S/c1-27(6-7-29)21(30)12-2-3-14-17(8-12)31-20-18(14)19(23-11-24-20)26-16-9-13-4-5-25-28(13)10-15(16)22/h4-5,9-12,29H,2-3,6-8H2,1H3,(H,23,24,26)/t12-/m0/s1 WSVWXPXQKLIAEP-LBPRGKRZSA-N 420149 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-(2-hydroxyethyl)-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 55 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 18.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420149&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844127 COCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H23ClN6O2S/c1-28(7-8-31-2)22(30)13-3-4-15-18(9-13)32-21-19(15)20(24-12-25-21)27-17-10-14-5-6-26-29(14)11-16(17)23/h5-6,10-13H,3-4,7-9H2,1-2H3,(H,24,25,27)/t13-/m0/s1 HMRWUITZTXTQGL-ZDUSSCGKSA-N 420151 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-(2-methoxyethyl)-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 56 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 41.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420151&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844128 CC(C)N(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H23ClN6OS/c1-12(2)28(3)22(30)13-4-5-15-18(8-13)31-21-19(15)20(24-11-25-21)27-17-9-14-6-7-26-29(14)10-16(17)23/h6-7,9-13H,4-5,8H2,1-3H3,(H,24,25,27)/t13-/m0/s1 LLOXFOSPXSEBHS-ZDUSSCGKSA-N 420152 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-N-(propan-2-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 57 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420152&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844129 CN(C)[C@@H]1CCN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H26ClN7OS/c1-30(2)16-6-8-31(11-16)24(33)14-3-4-17-20(9-14)34-23-21(17)22(26-13-27-23)29-19-10-15-5-7-28-32(15)12-18(19)25/h5,7,10,12-14,16H,3-4,6,8-9,11H2,1-2H3,(H,26,27,29)/t14-,16+/m0/s1 OXKGBMFHQKTRPN-GOEBONIOSA-N 420155 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone::US10487092, Example 58 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420155&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844130 CN(C)[C@H]1CCN(C1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H26ClN7OS/c1-30(2)16-6-8-31(11-16)24(33)14-3-4-17-20(9-14)34-23-21(17)22(26-13-27-23)29-19-10-15-5-7-28-32(15)12-18(19)25/h5,7,10,12-14,16H,3-4,6,8-9,11H2,1-2H3,(H,26,27,29)/t14-,16-/m0/s1 OXKGBMFHQKTRPN-HOCLYGCPSA-N 420157 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone::US10487092, Example 59 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420157&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844131 O[C@H]1CN(C[C@@H]1O)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H21ClN6O3S/c23-14-7-29-12(3-4-26-29)6-15(14)27-20-19-13-2-1-11(5-18(13)33-21(19)25-10-24-20)22(32)28-8-16(30)17(31)9-28/h3-4,6-7,10-11,16-17,30-31H,1-2,5,8-9H2,(H,24,25,27)/t11-,16-,17-/m0/s1 ZLQOWMVYFHUHKC-GOPGUHFVSA-N 420158 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]methanone::US10487092, Example 60 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 18.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420158&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844132 CN(C)C1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C25H28ClN7OS/c1-31(2)16-6-9-32(10-7-16)25(34)15-3-4-18-21(11-15)35-24-22(18)23(27-14-28-24)30-20-12-17-5-8-29-33(17)13-19(20)26/h5,8,12-16H,3-4,6-7,9-11H2,1-2H3,(H,27,28,30)/t15-/m0/s1 LLZZBDUELQHOOJ-HNNXBMFYSA-N 420159 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[4-(dimethylamino)piperidin-1-yl]methanone::US10487092, Example 61 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 13.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420159&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844133 CN(C)CCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H26ClN7OS/c1-29(2)8-9-30(3)23(32)14-4-5-16-19(10-14)33-22-20(16)21(25-13-26-22)28-18-11-15-6-7-27-31(15)12-17(18)24/h6-7,11-14H,4-5,8-10H2,1-3H3,(H,25,26,28)/t14-/m0/s1 QVOJKNKLERRTAF-AWEZNQCLSA-N 420146 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-[2-(dimethylamino)ethyl]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 53::US10487092, Example 62 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420146&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844134 CN(C)CCCN(CCO)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C25H30ClN7O2S/c1-31(2)8-3-9-32(10-11-34)25(35)16-4-5-18-21(12-16)36-24-22(18)23(27-15-28-24)30-20-13-17-6-7-29-33(17)14-19(20)26/h6-7,13-16,34H,3-5,8-12H2,1-2H3,(H,27,28,30)/t16-/m0/s1 XNECROIOBIZNTN-INIZCTEOSA-N 420164 (7S)4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-[3-(dimethylamino)propyl]-N-(2-hydroxyethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 63 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 15.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420164&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844135 C[C@H]1CN(C[C@@H](C)O1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H25ClN6O2S/c1-13-9-30(10-14(2)33-13)24(32)15-3-4-17-20(7-15)34-23-21(17)22(26-12-27-23)29-19-8-16-5-6-28-31(16)11-18(19)25/h5-6,8,11-15H,3-4,7,9-10H2,1-2H3,(H,26,27,29)/t13-,14+,15-/m0/s1 FXKHPSAEFUDDTD-ZNMIVQPWSA-N 420165 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(2R,6S)-2,6-dimethylmorpholin-4-yl]methanone::US10487092, Example 64 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 10.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420165&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844136 CN1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H24ClN7OS/c1-29-6-8-30(9-7-29)23(32)14-2-3-16-19(10-14)33-22-20(16)21(25-13-26-22)28-18-11-15-4-5-27-31(15)12-17(18)24/h4-5,11-14H,2-3,6-10H2,1H3,(H,25,26,28)/t14-/m0/s1 LRKNVLPJSFCRFQ-AWEZNQCLSA-N 420166 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl(4-methylpiperazin-1-yl)methanone::US10487092, Example 65 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420166&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844137 CN(C)CCN1CCN(CC1)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C26H31ClN8OS/c1-32(2)7-8-33-9-11-34(12-10-33)26(36)17-3-4-19-22(13-17)37-25-23(19)24(28-16-29-25)31-21-14-18-5-6-30-35(18)15-20(21)27/h5-6,14-17H,3-4,7-13H2,1-2H3,(H,28,29,31)/t17-/m0/s1 QUAHHDOGHWMNSY-KRWDZBQOSA-N 420167 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl4-[2-(dimethylamino)ethyl]piperazin-1-ylmethanone::US10487092, Example 66 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420167&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844138 CCN(CCN(C)C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H28ClN7OS/c1-4-31(10-9-30(2)3)24(33)15-5-6-17-20(11-15)34-23-21(17)22(26-14-27-23)29-19-12-16-7-8-28-32(16)13-18(19)25/h7-8,12-15H,4-6,9-11H2,1-3H3,(H,26,27,29)/t15-/m0/s1 OLRGNYASSOIUDB-HNNXBMFYSA-N 420168 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-[2-(dimethylamino)ethyl]-N-ethyl-3,5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 67 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 30.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420168&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844139 Clc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCOCC1 InChI=1S/C22H21ClN6O2S/c23-16-11-29-14(3-4-26-29)10-17(16)27-20-19-15-2-1-13(22(30)28-5-7-31-8-6-28)9-18(15)32-21(19)25-12-24-20/h3-4,10-13H,1-2,5-9H2,(H,24,25,27)/t13-/m0/s1 MRABRCSZYKLRPM-ZDUSSCGKSA-N 420169 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl(morpholin-4-yl)methanone::US10487092, Example 68 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420169&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844140 CCN(CCO)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C22H23ClN6O2S/c1-2-28(7-8-30)22(31)13-3-4-15-18(9-13)32-21-19(15)20(24-12-25-21)27-17-10-14-5-6-26-29(14)11-16(17)23/h5-6,10-13,30H,2-4,7-9H2,1H3,(H,24,25,27)/t13-/m0/s1 BSSGBZAQESTBBO-ZDUSSCGKSA-N 420174 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-ethyl-N-(2-hydroxyethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 69 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 6.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420174&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844141 CCN(CCOC)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H25ClN6O2S/c1-3-29(8-9-32-2)23(31)14-4-5-16-19(10-14)33-22-20(16)21(25-13-26-22)28-18-11-15-6-7-27-30(15)12-17(18)24/h6-7,11-14H,3-5,8-10H2,1-2H3,(H,25,26,28)/t14-/m0/s1 HAGFJHNRECVSAC-AWEZNQCLSA-N 420175 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N-ethyl-N-(2-methoxyethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 70 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420175&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844142 COCCN(CCOC)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H27ClN6O3S/c1-33-9-7-30(8-10-34-2)24(32)15-3-4-17-20(11-15)35-23-21(17)22(26-14-27-23)29-19-12-16-5-6-28-31(16)13-18(19)25/h5-6,12-15H,3-4,7-11H2,1-2H3,(H,26,27,29)/t15-/m0/s1 AZOBNEMSGCPFMN-HNNXBMFYSA-N 420176 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-N,N-bis(2-methoxyethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 71 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 12.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420176&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844143 CN1C[C@@H]2C[C@H]1CN2C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H24ClN7OS/c1-30-9-16-7-15(30)10-31(16)24(33)13-2-3-17-20(6-13)34-23-21(17)22(26-12-27-23)29-19-8-14-4-5-28-32(14)11-18(19)25/h4-5,8,11-13,15-16H,2-3,6-7,9-10H2,1H3,(H,26,27,29)/t13-,15-,16-/m0/s1 CNVCZSCFVUDWJF-BPUTZDHNSA-N 420183 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]methanone::US10487092, Example 72 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 14.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420183&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844144 CN1C[C@H]2C[C@@H]1CN2C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C24H24ClN7OS/c1-30-9-16-7-15(30)10-31(16)24(33)13-2-3-17-20(6-13)34-23-21(17)22(26-12-27-23)29-19-8-14-4-5-28-32(14)11-18(19)25/h4-5,8,11-13,15-16H,2-3,6-7,9-10H2,1H3,(H,26,27,29)/t13-,15+,16+/m0/s1 CNVCZSCFVUDWJF-NUEKZKHPSA-N 420184 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]methanone::US10487092, Example 73 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420184&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844145 Clc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@@H]2C[C@H]1CO2 InChI=1S/C23H21ClN6O2S/c24-17-9-30-13(3-4-27-30)7-18(17)28-21-20-16-2-1-12(5-19(16)33-22(20)26-11-25-21)23(31)29-8-15-6-14(29)10-32-15/h3-4,7,9,11-12,14-15H,1-2,5-6,8,10H2,(H,25,26,28)/t12-,14-,15-/m0/s1 PBTMTOQZGPQPGI-QEJZJMRPSA-N 420186 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl]methanone::US10487092, Example 74 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 22.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420186&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844146 Clc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@H]2C[C@@H]1CO2 InChI=1S/C23H21ClN6O2S/c24-17-9-30-13(3-4-27-30)7-18(17)28-21-20-16-2-1-12(5-19(16)33-22(20)26-11-25-21)23(31)29-8-15-6-14(29)10-32-15/h3-4,7,9,11-12,14-15H,1-2,5-6,8,10H2,(H,25,26,28)/t12-,14+,15+/m0/s1 PBTMTOQZGPQPGI-NWANDNLSSA-N 420187 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl]methanone::US10487092, Example 75 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 56.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420187&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844147 C[C@H]1COCCN1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H23ClN6O2S/c1-13-11-32-7-6-29(13)23(31)14-2-3-16-19(8-14)33-22-20(16)21(25-12-26-22)28-18-9-15-4-5-27-30(15)10-17(18)24/h4-5,9-10,12-14H,2-3,6-8,11H2,1H3,(H,25,26,28)/t13-,14-/m0/s1 XGYHCBMUEFQEGI-KBPBESRZSA-N 420189 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3S)-3-methylmorpholin-4-yl]methanone::US10487092, Example 76 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420189&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844148 C[C@@H]1COCCN1C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3Cl)c21 InChI=1S/C23H23ClN6O2S/c1-13-11-32-7-6-29(13)23(31)14-2-3-16-19(8-14)33-22-20(16)21(25-12-26-22)28-18-9-15-4-5-27-30(15)10-17(18)24/h4-5,9-10,12-14H,2-3,6-8,11H2,1H3,(H,25,26,28)/t13-,14+/m1/s1 XGYHCBMUEFQEGI-KGLIPLIRSA-N 420191 (7S)-4-[(6-Chloropyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3R)-3-methylmorpholin-4-yl]methanone::US10487092, Example 77 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 21.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420191&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844149 CNC(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C20H20N6O2S/c1-21-19(27)11-3-4-13-16(7-11)29-20-17(13)18(22-10-23-20)25-14-8-12-5-6-24-26(12)9-15(14)28-2/h5-6,8-11H,3-4,7H2,1-2H3,(H,21,27)(H,22,23,25)/t11-/m0/s1 DXPVFTASDLJHRU-NSHDSACASA-N 420192 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 78 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420192&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844150 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NCC(F)F InChI=1S/C20H19F2N7O2S/c1-31-12-8-29-15(4-5-26-29)27-17(12)28-18-16-11-3-2-10(19(30)23-7-14(21)22)6-13(11)32-20(16)25-9-24-18/h4-5,8-10,14H,2-3,6-7H2,1H3,(H,23,30)(H,24,25,27,28)/t10-/m0/s1 UGGSIUOQKBBFHF-JTQLQIEISA-N 420193 (7S)—N-(2,2-Difluoroethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 79 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420193&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844151 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NCCC(F)(F)F InChI=1S/C21H20F3N7O2S/c1-33-13-9-31-15(4-6-28-31)29-17(13)30-18-16-12-3-2-11(19(32)25-7-5-21(22,23)24)8-14(12)34-20(16)27-10-26-18/h4,6,9-11H,2-3,5,7-8H2,1H3,(H,25,32)(H,26,27,29,30)/t11-/m0/s1 LEWFKKWUHPZBNT-NSHDSACASA-N 420194 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-(3,3,3-trifluoropropyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 80 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420194&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844152 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NCC(C)(C)O InChI=1S/C22H25N7O3S/c1-22(2,31)10-23-20(30)12-4-5-13-15(8-12)33-21-17(13)19(24-11-25-21)28-18-14(32-3)9-29-16(27-18)6-7-26-29/h6-7,9,11-12,31H,4-5,8,10H2,1-3H3,(H,23,30)(H,24,25,27,28)/t12-/m0/s1 NKYJKCZMKUMMTQ-LBPRGKRZSA-N 420195 (7S)—N-(2-Hydroxy-2-methylpropyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 81 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420195&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844153 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NCCN(C)C InChI=1S/C22H26N8O2S/c1-29(2)9-8-23-21(31)13-4-5-14-16(10-13)33-22-18(14)20(24-12-25-22)28-19-15(32-3)11-30-17(27-19)6-7-26-30/h6-7,11-13H,4-5,8-10H2,1-3H3,(H,23,31)(H,24,25,27,28)/t13-/m0/s1 XNRHQBBUSRHRFE-ZDUSSCGKSA-N 420196 (7S)—N-[2-(Dimethylamino)ethyl]-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 82 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420196&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844154 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NCCO InChI=1S/C20H21N7O3S/c1-30-13-9-27-15(4-5-24-27)25-17(13)26-18-16-12-3-2-11(19(29)21-6-7-28)8-14(12)31-20(16)23-10-22-18/h4-5,9-11,28H,2-3,6-8H2,1H3,(H,21,29)(H,22,23,25,26)/t11-/m0/s1 JKZHFMYLGLGOLL-NSHDSACASA-N 420197 (7S)—N-(2-Hydroxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 83 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420197&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search C04080 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844155 COCCNC(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3nc4ccnn4cc3OC)c21 InChI=1S/C21H23N7O3S/c1-30-8-7-22-20(29)12-3-4-13-15(9-12)32-21-17(13)19(23-11-24-21)27-18-14(31-2)10-28-16(26-18)5-6-25-28/h5-6,10-12H,3-4,7-9H2,1-2H3,(H,22,29)(H,23,24,26,27)/t12-/m0/s1 KKTVSMWQEJEQHC-LBPRGKRZSA-N 420198 (7S)—N-(2-Methoxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 84 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420198&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844156 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NC(C)C InChI=1S/C21H23N7O2S/c1-11(2)25-20(29)12-4-5-13-15(8-12)31-21-17(13)19(22-10-23-21)27-18-14(30-3)9-28-16(26-18)6-7-24-28/h6-7,9-12H,4-5,8H2,1-3H3,(H,25,29)(H,22,23,26,27)/t12-/m0/s1 DITKDRUGVJFECR-LBPRGKRZSA-N 420199 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-(propan-2-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 85 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420199&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844157 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NC(C)(C)C InChI=1S/C22H25N7O2S/c1-22(2,3)28-20(30)12-5-6-13-15(9-12)32-21-17(13)19(23-11-24-21)27-18-14(31-4)10-29-16(26-18)7-8-25-29/h7-8,10-12H,5-6,9H2,1-4H3,(H,28,30)(H,23,24,26,27)/t12-/m0/s1 UVKCGHLOLUPRKB-LBPRGKRZSA-N 420200 (7S)—N-tert-Butyl-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 86 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420200&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844158 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)NC1(C)CCC1 InChI=1S/C23H25N7O2S/c1-23(7-3-8-23)29-21(31)13-4-5-14-16(10-13)33-22-18(14)20(24-12-25-22)28-19-15(32-2)11-30-17(27-19)6-9-26-30/h6,9,11-13H,3-5,7-8,10H2,1-2H3,(H,29,31)(H,24,25,27,28)/t13-/m0/s1 IFKXCMZRGWCSRT-ZDUSSCGKSA-N 420201 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-(1-methylcyclobutyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 87 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 4.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420201&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844159 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1ccc(F)cc1 InChI=1S/C24H20FN7O2S/c1-34-17-11-32-19(8-9-28-32)30-21(17)31-22-20-16-7-2-13(10-18(16)35-24(20)27-12-26-22)23(33)29-15-5-3-14(25)4-6-15/h3-6,8-9,11-13H,2,7,10H2,1H3,(H,29,33)(H,26,27,30,31)/t13-/m0/s1 IPGWCOZSAGQKNL-ZDUSSCGKSA-N 420203 (7S)—N-(4-Fluorophenyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 88 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 8.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420203&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844160 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1cccc(Cl)c1 InChI=1S/C24H20ClN7O2S/c1-34-17-11-32-19(7-8-28-32)30-21(17)31-22-20-16-6-5-13(9-18(16)35-24(20)27-12-26-22)23(33)29-15-4-2-3-14(25)10-15/h2-4,7-8,10-13H,5-6,9H2,1H3,(H,29,33)(H,26,27,30,31)/t13-/m0/s1 WTNLLFNQDFVWGB-ZDUSSCGKSA-N 420204 (7S)—N-(3-Chlorophenyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 89 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 24.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420204&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844161 COc1cn2nccc2nc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1ccc(Cl)c(Cl)c1 InChI=1S/C24H19Cl2N7O2S/c1-35-17-10-33-19(6-7-29-33)31-21(17)32-22-20-14-4-2-12(8-18(14)36-24(20)28-11-27-22)23(34)30-13-3-5-15(25)16(26)9-13/h3,5-7,9-12H,2,4,8H2,1H3,(H,30,34)(H,27,28,31,32)/t12-/m0/s1 CDFMMLABKAVCQN-LBPRGKRZSA-N 420206 (7S)—N-(3,4-Dichlorophenyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 90 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 235 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420206&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844162 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1ccc(F)c(Cl)c1 InChI=1S/C25H20ClFN6O2S/c1-35-20-11-33-15(6-7-30-33)10-19(20)32-23-22-16-4-2-13(8-21(16)36-25(22)29-12-28-23)24(34)31-14-3-5-18(27)17(26)9-14/h3,5-7,9-13H,2,4,8H2,1H3,(H,31,34)(H,28,29,32)/t13-/m0/s1 HKMZFIPGKDEZAA-ZDUSSCGKSA-N 420208 (7S)—N-(3-Chloro-4-fluorophenyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 91 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 48.0 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420208&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844163 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1cccc(F)c1 InChI=1S/C25H21FN6O2S/c1-34-20-12-32-17(7-8-29-32)11-19(20)31-23-22-18-6-5-14(9-21(18)35-25(22)28-13-27-23)24(33)30-16-4-2-3-15(26)10-16/h2-4,7-8,10-14H,5-6,9H2,1H3,(H,30,33)(H,27,28,31)/t14-/m0/s1 WVNPKOQLVXNOGS-AWEZNQCLSA-N 420210 (7S)—N-(3-Fluorophenyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 92 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420210&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844164 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)Nc1ccc2[nH]ccc2c1 420222 (7S)—N-(1H-Indol-5-yl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 93 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420222&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844165 CCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C22H24N6O2S/c1-4-27(2)22(29)13-5-6-15-18(9-13)31-21-19(15)20(23-12-24-21)26-16-10-14-7-8-25-28(14)11-17(16)30-3/h7-8,10-13H,4-6,9H2,1-3H3,(H,23,24,26)/t13-/m0/s1 DPMVIICLHDHFSX-ZDUSSCGKSA-N 420246 (7S)—N-Ethyl-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 94 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420246&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844166 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)CC(F)F InChI=1S/C22H22F2N6O2S/c1-29(10-18(23)24)22(31)12-3-4-14-17(7-12)33-21-19(14)20(25-11-26-21)28-15-8-13-5-6-27-30(13)9-16(15)32-2/h5-6,8-9,11-12,18H,3-4,7,10H2,1-2H3,(H,25,26,28)/t12-/m0/s1 KVALNBNHGYOQHR-LBPRGKRZSA-N 420247 (7S)—N-(2,2-Difluoroethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 95 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420247&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844167 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)CCC(F)(F)F InChI=1S/C23H23F3N6O2S/c1-31(8-6-23(24,25)26)22(33)13-3-4-15-18(9-13)35-21-19(15)20(27-12-28-21)30-16-10-14-5-7-29-32(14)11-17(16)34-2/h5,7,10-13H,3-4,6,8-9H2,1-2H3,(H,27,28,30)/t13-/m0/s1 YHRCZDIWJYFQEG-ZDUSSCGKSA-N 420248 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-N-(3,3,3-trifluoropropyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 96 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 7.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420248&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844168 CCCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C24H28N6O2S/c1-4-5-10-29(2)24(31)15-6-7-17-20(11-15)33-23-21(17)22(25-14-26-23)28-18-12-16-8-9-27-30(16)13-19(18)32-3/h8-9,12-15H,4-7,10-11H2,1-3H3,(H,25,26,28)/t15-/m0/s1 NCFAQVRKGXSEAZ-HNNXBMFYSA-N 420249 (7S)—N-Butyl-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 97 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420249&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844169 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC(C1)C#N InChI=1S/C23H21N7O2S/c1-32-18-11-30-15(4-5-27-30)7-17(18)28-21-20-16-3-2-14(23(31)29-9-13(8-24)10-29)6-19(16)33-22(20)26-12-25-21/h4-5,7,11-14H,2-3,6,9-10H2,1H3,(H,25,26,28)/t14-/m0/s1 PSGOWTPRKWLTCN-AWEZNQCLSA-N 420250 1-((7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylcarbonyl)azetidine-3-carbonitrile::US10487092, Example 98 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420250&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844170 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)CCCN(C)C InChI=1S/C25H31N7O2S/c1-30(2)10-5-11-31(3)25(33)16-6-7-18-21(12-16)35-24-22(18)23(26-15-27-24)29-19-13-17-8-9-28-32(17)14-20(19)34-4/h8-9,13-16H,5-7,10-12H2,1-4H3,(H,26,27,29)/t16-/m0/s1 JIYAVBHVKKZTRD-INIZCTEOSA-N 420251 (7S)—N-[3-(Dimethylamino)propyl]-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 99 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420251&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844171 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC(C)(O)C1 InChI=1S/C23H24N6O3S/c1-23(31)10-28(11-23)22(30)13-3-4-15-18(7-13)33-21-19(15)20(24-12-25-21)27-16-8-14-5-6-26-29(14)9-17(16)32-2/h5-6,8-9,12-13,31H,3-4,7,10-11H2,1-2H3,(H,24,25,27)/t13-/m0/s1 FKAIUMRWXKFQQA-ZDUSSCGKSA-N 420252 (3-Hydroxy-3-methylazetidin-1-yl)(7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone::US10487092, Example 100 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420252&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844172 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)CCN(C)C InChI=1S/C24H29N7O2S/c1-29(2)9-10-30(3)24(32)15-5-6-17-20(11-15)34-23-21(17)22(25-14-26-23)28-18-12-16-7-8-27-31(16)13-19(18)33-4/h7-8,12-15H,5-6,9-11H2,1-4H3,(H,25,26,28)/t15-/m0/s1 ATSVREJKSONIJK-HNNXBMFYSA-N 420253 (7S)—N-[2-(Dimethylamino)ethyl]-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 101 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420253&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844173 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC(C1)N(C)C InChI=1S/C24H27N7O2S/c1-29(2)16-10-30(11-16)24(32)14-4-5-17-20(8-14)34-23-21(17)22(25-13-26-23)28-18-9-15-6-7-27-31(15)12-19(18)33-3/h6-7,9,12-14,16H,4-5,8,10-11H2,1-3H3,(H,25,26,28)/t14-/m0/s1 VJQBMDQILRCOLE-AWEZNQCLSA-N 420254 US10487092, Example 102::[3-(Dimethylamino)azetidin-1-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420254&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844174 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)CCO InChI=1S/C22H24N6O3S/c1-27(7-8-29)22(30)13-3-4-15-18(9-13)32-21-19(15)20(23-12-24-21)26-16-10-14-5-6-25-28(14)11-17(16)31-2/h5-6,10-13,29H,3-4,7-9H2,1-2H3,(H,23,24,26)/t13-/m0/s1 CSKBFMDCARHZHM-ZDUSSCGKSA-N 420255 (7S)—N-(2-Hydroxyethyl)-4-[(6-methoxypyrazolo [1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 103 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420255&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844175 COCCN(C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C23H26N6O3S/c1-28(8-9-31-2)23(30)14-4-5-16-19(10-14)33-22-20(16)21(24-13-25-22)27-17-11-15-6-7-26-29(15)12-18(17)32-3/h6-7,11-14H,4-5,8-10H2,1-3H3,(H,24,25,27)/t14-/m0/s1 PYGNEARBCARCRB-AWEZNQCLSA-N 420256 (7S)—N-(2-Methoxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 104 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420256&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844176 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)C(C)C InChI=1S/C23H26N6O2S/c1-13(2)28(3)23(30)14-5-6-16-19(9-14)32-22-20(16)21(24-12-25-22)27-17-10-15-7-8-26-29(15)11-18(17)31-4/h7-8,10-14H,5-6,9H2,1-4H3,(H,24,25,27)/t14-/m0/s1 OICUHWPRUCTFQY-AWEZNQCLSA-N 420257 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-N-(propan-2-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 105 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420257&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844177 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC[C@H](C1)N(C)C InChI=1S/C25H29N7O2S/c1-30(2)17-7-9-31(12-17)25(33)15-4-5-18-21(10-15)35-24-22(18)23(26-14-27-24)29-19-11-16-6-8-28-32(16)13-20(19)34-3/h6,8,11,13-15,17H,4-5,7,9-10,12H2,1-3H3,(H,26,27,29)/t15-,17+/m0/s1 ARYUOKUQUHEUHN-DOTOQJQBSA-N 420258 US10487092, Example 106::[(3R)-3-(Dimethylamino)pyrrolidin-1-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420258&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844178 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CC[C@@H](C1)N(C)C InChI=1S/C25H29N7O2S/c1-30(2)17-7-9-31(12-17)25(33)15-4-5-18-21(10-15)35-24-22(18)23(26-14-27-24)29-19-11-16-6-8-28-32(16)13-20(19)34-3/h6,8,11,13-15,17H,4-5,7,9-10,12H2,1-3H3,(H,26,27,29)/t15-,17-/m0/s1 ARYUOKUQUHEUHN-RDJZCZTQSA-N 420259 US10487092, Example 107::[(3S)-3-(Dimethylamino)pyrrolidin-1-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420259&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844179 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@H](O)[C@@H](O)C1 InChI=1S/C23H24N6O4S/c1-33-18-10-29-13(4-5-26-29)7-15(18)27-21-20-14-3-2-12(6-19(14)34-22(20)25-11-24-21)23(32)28-8-16(30)17(31)9-28/h4-5,7,10-12,16-17,30-31H,2-3,6,8-9H2,1H3,(H,24,25,27)/t12-,16-,17-/m0/s1 KYXWFSTVEZAOSK-ZLIFDBKOSA-N 420260 US10487092, Example 108::[(3S,4S)-3,4-Dihydroxypyrrolidin-1-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420260&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844180 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCC(CC1)N(C)C InChI=1S/C26H31N7O2S/c1-31(2)17-7-10-32(11-8-17)26(34)16-4-5-19-22(12-16)36-25-23(19)24(27-15-28-25)30-20-13-18-6-9-29-33(18)14-21(20)35-3/h6,9,13-17H,4-5,7-8,10-12H2,1-3H3,(H,27,28,30)/t16-/m0/s1 MRKSLFPWRDHADJ-INIZCTEOSA-N 420261 US10487092, Example 109::[4-(Dimethylamino)piperidin-1-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420261&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844181 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCC(CC1)N(C)CCN(C)C InChI=1S/C29H38N8O2S/c1-34(2)13-14-35(3)20-8-11-36(12-9-20)29(38)19-5-6-22-25(15-19)40-28-26(22)27(30-18-31-28)33-23-16-21-7-10-32-37(21)17-24(23)39-4/h7,10,16-20H,5-6,8-9,11-15H2,1-4H3,(H,30,31,33)/t19-/m0/s1 FVCYTIPQPWVBDR-IBGZPJMESA-N 420262 (4-[2-Dimethylamino)ethyl]methyl)aminopiperidin-1-yl)(7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone::US10487092, Example 110 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420262&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844182 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(CCO)CCCN(C)C InChI=1S/C26H33N7O3S/c1-31(2)9-4-10-32(11-12-34)26(35)17-5-6-19-22(13-17)37-25-23(19)24(27-16-28-25)30-20-14-18-7-8-29-33(18)15-21(20)36-3/h7-8,14-17,34H,4-6,9-13H2,1-3H3,(H,27,28,30)/t17-/m0/s1 MJUUQTWPDSUVQW-KRWDZBQOSA-N 420263 (7S)—N-[3-(Dimethylamino)propyl]-N-(2-hydroxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 111 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 3.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420263&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844183 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@H](C)O[C@H](C)C1 InChI=1S/C25H28N6O3S/c1-14-10-30(11-15(2)34-14)25(32)16-4-5-18-21(8-16)35-24-22(18)23(26-13-27-24)29-19-9-17-6-7-28-31(17)12-20(19)33-3/h6-7,9,12-16H,4-5,8,10-11H2,1-3H3,(H,26,27,29)/t14-,15+,16-/m0/s1 OLDQBABKGQZXGF-XHSDSOJGSA-N 420264 US10487092, Example 112::[(2R,6S)-2,6-Dimethylmorpholin-4-yl](7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420264&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844184 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCN(C)CC1 InChI=1S/C24H27N7O2S/c1-29-7-9-30(10-8-29)24(32)15-3-4-17-20(11-15)34-23-21(17)22(25-14-26-23)28-18-12-16-5-6-27-31(16)13-19(18)33-2/h5-6,12-15H,3-4,7-11H2,1-2H3,(H,25,26,28)/t15-/m0/s1 KLQMCERMAYQBDJ-HNNXBMFYSA-N 420265 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl(4-methylpiperazin-1-yl)methanone::US10487092, Example 113 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420265&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844185 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCN(CCN(C)C)CC1 InChI=1S/C27H34N8O2S/c1-32(2)8-9-33-10-12-34(13-11-33)27(36)18-4-5-20-23(14-18)38-26-24(20)25(28-17-29-26)31-21-15-19-6-7-30-35(19)16-22(21)37-3/h6-7,15-18H,4-5,8-14H2,1-3H3,(H,28,29,31)/t18-/m0/s1 DVDFFAFFXSOSJJ-SFHVURJKSA-N 420266 4-[2-(Dimethylamino)ethyl]piperazin-1-yl(7S)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-ylmethanone::US10487092, Example 114 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420266&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844186 CCN(CCN(C)C)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C25H31N7O2S/c1-5-31(11-10-30(2)3)25(33)16-6-7-18-21(12-16)35-24-22(18)23(26-15-27-24)29-19-13-17-8-9-28-32(17)14-20(19)34-4/h8-9,13-16H,5-7,10-12H2,1-4H3,(H,26,27,29)/t16-/m0/s1 CQZIAKSQBKTMIT-INIZCTEOSA-N 420267 (7S)—N-[2-(Dimethylamino)ethyl]-N-ethyl-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 115 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420267&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844187 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCOCC1 InChI=1S/C23H24N6O3S/c1-31-18-12-29-15(4-5-26-29)11-17(18)27-21-20-16-3-2-14(23(30)28-6-8-32-9-7-28)10-19(16)33-22(20)25-13-24-21/h4-5,11-14H,2-3,6-10H2,1H3,(H,24,25,27)/t14-/m0/s1 QMPLQZWNIXAOIC-AWEZNQCLSA-N 420268 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl(morpholin-4-yl)methanone::US10487092, Example 116 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420268&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844188 CCN(CCO)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C23H26N6O3S/c1-3-28(8-9-30)23(31)14-4-5-16-19(10-14)33-22-20(16)21(24-13-25-22)27-17-11-15-6-7-26-29(15)12-18(17)32-2/h6-7,11-14,30H,3-5,8-10H2,1-2H3,(H,24,25,27)/t14-/m0/s1 ZFCQVNVVGHUUNF-AWEZNQCLSA-N 420269 (7S)—N-Ethyl-N-(2-hydroxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 117 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420269&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844189 CCN(CCOC)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C24H28N6O3S/c1-4-29(9-10-32-2)24(31)15-5-6-17-20(11-15)34-23-21(17)22(25-14-26-23)28-18-12-16-7-8-27-30(16)13-19(18)33-3/h7-8,12-15H,4-6,9-11H2,1-3H3,(H,25,26,28)/t15-/m0/s1 SNWHKHIPEMMJFQ-HNNXBMFYSA-N 420270 (7S)—N-Ethyl-N-(2-methoxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 118 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420270&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844190 COCCN(CCOC)C(=O)[C@H]1CCc2c(C1)sc1ncnc(Nc3cc4ccnn4cc3OC)c21 InChI=1S/C25H30N6O4S/c1-33-10-8-30(9-11-34-2)25(32)16-4-5-18-21(12-16)36-24-22(18)23(26-15-27-24)29-19-13-17-6-7-28-31(17)14-20(19)35-3/h6-7,13-16H,4-5,8-12H2,1-3H3,(H,26,27,29)/t16-/m0/s1 GBIFLAVNMKHWFS-INIZCTEOSA-N 420271 (7S)—N,N-Bis(2-methoxyethyl)-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 119 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420271&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844191 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N(C)C(C)(C)C InChI=1S/C24H28N6O2S/c1-24(2,3)29(4)23(31)14-6-7-16-19(10-14)33-22-20(16)21(25-13-26-22)28-17-11-15-8-9-27-30(15)12-18(17)32-5/h8-9,11-14H,6-7,10H2,1-5H3,(H,25,26,28)/t14-/m0/s1 FTPNOAKCKBUDCG-AWEZNQCLSA-N 420272 (7S)—N-tert-Butyl-4-[(6-methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-N-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide::US10487092, Example 120 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 5.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420272&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844192 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@@H]2C[C@H]1CN2C InChI=1S/C25H27N7O2S/c1-30-10-17-8-16(30)11-31(17)25(33)14-3-4-18-21(7-14)35-24-22(18)23(26-13-27-24)29-19-9-15-5-6-28-32(15)12-20(19)34-2/h5-6,9,12-14,16-17H,3-4,7-8,10-11H2,1-2H3,(H,26,27,29)/t14-,16-,17-/m0/s1 HKYAMGNKONTKKL-XIRDDKMYSA-N 420273 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]methanone::US10487092, Example 121 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420273&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844193 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@H]2C[C@@H]1CN2C InChI=1S/C25H27N7O2S/c1-30-10-17-8-16(30)11-31(17)25(33)14-3-4-18-21(7-14)35-24-22(18)23(26-13-27-24)29-19-9-15-5-6-28-32(15)12-20(19)34-2/h5-6,9,12-14,16-17H,3-4,7-8,10-11H2,1-2H3,(H,26,27,29)/t14-,16+,17+/m0/s1 HKYAMGNKONTKKL-USXIJHARSA-N 420274 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]methanone::US10487092, Example 122 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] <1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420274&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844194 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@@H]2C[C@H]1CO2 InChI=1S/C24H24N6O3S/c1-32-19-10-30-14(4-5-27-30)8-18(19)28-22-21-17-3-2-13(6-20(17)34-23(21)26-12-25-22)24(31)29-9-16-7-15(29)11-33-16/h4-5,8,10,12-13,15-16H,2-3,6-7,9,11H2,1H3,(H,25,26,28)/t13-,15-,16-/m0/s1 HUGQUBQNZPMAHN-BPUTZDHNSA-N 420275 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl]methanone::US10487092, Example 123 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 2.00 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420275&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844195 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1C[C@H]2C[C@@H]1CO2 InChI=1S/C24H24N6O3S/c1-32-19-10-30-14(4-5-27-30)8-18(19)28-22-21-17-3-2-13(6-20(17)34-23(21)26-12-25-22)24(31)29-9-16-7-15(29)11-33-16/h4-5,8,10,12-13,15-16H,2-3,6-7,9,11H2,1H3,(H,25,26,28)/t13-,15+,16+/m0/s1 HUGQUBQNZPMAHN-NUEKZKHPSA-N 420276 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl]methanone::US10487092, Example 124 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420276&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844196 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCOC[C@@H]1C InChI=1S/C24H26N6O3S/c1-14-12-33-8-7-29(14)24(31)15-3-4-17-20(9-15)34-23-21(17)22(25-13-26-23)28-18-10-16-5-6-27-30(16)11-19(18)32-2/h5-6,10-11,13-15H,3-4,7-9,12H2,1-2H3,(H,25,26,28)/t14-,15-/m0/s1 GVRVCVKJXBIZNZ-GJZGRUSLSA-N 420277 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3S)-3-methylmorpholin-4-yl]methanone::US10487092, Example 125 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420277&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 844197 COc1cn2nccc2cc1Nc1ncnc2sc3C[C@H](CCc3c12)C(=O)N1CCOC[C@H]1C InChI=1S/C24H26N6O3S/c1-14-12-33-8-7-29(14)24(31)15-3-4-17-20(9-15)34-23-21(17)22(25-13-26-23)28-18-10-16-5-6-27-30(16)11-19(18)32-2/h5-6,10-11,13-15H,3-4,7-9,12H2,1-2H3,(H,25,26,28)/t14-,15+/m1/s1 GVRVCVKJXBIZNZ-CABCVRRESA-N 420278 (7S)-4-[(6-Methoxypyrazolo[1,5-a]pyridin-5-yl)amino]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-7-yl[(3R)-3-methylmorpholin-4-yl]methanone::US10487092, Example 126 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] 1.000 US Patent 10.7270/Q28W3GPZ aid1803973 US10487092 Giese, A; Klar, U; Graham, K; Kettschau, G; Sulzle, D; Lienau, P; Petersen, K; LeFranc, J; Schmidt, N BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420278&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6